Target Binding Site Detail
Target General Information | Top | ||||
---|---|---|---|---|---|
Target ID | T59480 | Target Info | |||
Target Name | KRAS G12C mutant (KRAS G12C) | ||||
Target Type | Successful Target | ||||
Gene Name | KRAS | ||||
UniProt ID |
Ligand General Information | Top | ||||
---|---|---|---|---|---|
Ligand Name | Guanosine-5'-Diphosphate | Ligand Info | |||
Canonical SMILES | C1=NC2=C(N1C3C(C(C(O3)COP(=O)(O)OP(=O)(O)O)O)O)N=C(NC2=O)N | ||||
InChI | 1S/C10H15N5O11P2/c11-10-13-7-4(8(18)14-10)12-2-15(7)9-6(17)5(16)3(25-9)1-24-28(22,23)26-27(19,20)21/h2-3,5-6,9,16-17H,1H2,(H,22,23)(H2,19,20,21)(H3,11,13,14,18)/t3-,5-,6-,9-/m1/s1 | ||||
InChIKey | QGWNDRXFNXRZMB-UUOKFMHZSA-N | ||||
PubChem Compound ID | 135398619 |
Drug Binding Sites of Target | Top | |||||
---|---|---|---|---|---|---|
PDB ID: 6PGP Crystal structure of human KRAS G12C covalently bound to a quinazolinone inhibitor | ||||||
Method | X-ray diffraction | Resolution | 1.50 Å | Mutation | Yes | [1] |
PDB Sequence |
MTEYKLVVVG
10 ACGVGKSALT20 IQLIQNHFVD30 EYDPTIEDSY40 RKQVVIDGET50 SLLDILDTAG 60 QEEYSAMRDQ70 YMRTGEGFLL80 VFAINNTKSF90 EDIHHYREQI100 KRVKDSEDVP 110 MVLVGNKSDL120 PSRTVDTKQA130 QDLARSYGIP140 FIETSAKTRQ150 GVDDAFYTLV 160 REIRKHKEK
|
|||||
|
ALA11
3.748
CYS12
3.853
GLY13
2.806
VAL14
3.320
GLY15
3.055
LYS16
2.836
SER17
3.018
ALA18
2.773
LEU19
4.988
PHE28
3.012
VAL29
3.328
ASP30
2.689
|
|||||
PDB ID: 8DNI Crystal structure of human KRAS G12C covalently bound with Araxes WO2020/028706A1 compound I-1 | ||||||
Method | X-ray diffraction | Resolution | 1.50 Å | Mutation | Yes | [2] |
PDB Sequence |
GMTEYKLVVV
9 GACGVGKSAL19 TIQLIQNHFV29 DEYDPTIEDS39 YRKQVVIDGE49 TSLLDILDTA 59 GQEEYSAMRD69 QYMRTGEGFL79 LVFAINNTKS89 FEDIHHYREQ99 IKRVKDSEDV 109 PMVLVGNKSD119 LPSRTVDTKQ129 AQDLARSYGI139 PFIETSAKTR149 QGVDDAFYTL 159 VREIRKHKEK169
|
|||||
|
ALA11
3.746
CYS12
3.946
GLY13
2.860
VAL14
3.338
GLY15
3.016
LYS16
2.735
SER17
2.917
ALA18
2.844
PHE28
3.427
VAL29
4.649
ASP30
2.831
GLU31
4.676
|
|||||
PDB ID: 6PGO Crystal structure of human KRAS G12C covalently bound to a phthalazine inhibitor | ||||||
Method | X-ray diffraction | Resolution | 1.60 Å | Mutation | Yes | [1] |
PDB Sequence |
MTEYKLVVVG
10 ACGVGKSALT20 IQLIQNHFVD30 EYDPTIEDSY40 RKQVVIDGET50 SLLDILDTAG 60 RDQYMRTGEG77 FLLVFAINNT87 KSFEDIHHYR97 EQIKRVKDSE107 DVPMVLVGNK 117 SDLPSRTVDT127 KQAQDLARSY137 GIPFIETSAK147 TRQGVDDAFY157 TLVREIRKHK 167
|
|||||
|
ALA11
3.817
CYS12
3.840
GLY13
2.784
VAL14
3.358
GLY15
2.980
LYS16
2.768
SER17
2.986
ALA18
2.799
PHE28
3.308
VAL29
3.916
ASP30
2.741
GLU31
3.169
|
|||||
PDB ID: 6OIM Crystal Structure of human KRAS G12C covalently bound to AMG 510 | ||||||
Method | X-ray diffraction | Resolution | 1.65 Å | Mutation | Yes | [3] |
PDB Sequence |
GMTEYKLVVV
9 GACGVGKSAL19 TIQLIQNHFV29 DEYDPTIEDS39 YRKQVVIDGE49 TSLLDILDTA 59 GQEEYSAMRD69 QYMRTGEGFL79 LVFAINNTKS89 FEDIHHYREQ99 IKRVKDVPMV 112 LVGNKSDLPS122 RTVDTKQAQD132 LARSYGIPFI142 ETSAKTRQGV152 DDAFYTLVRE 162 IRKHKEK
|
|||||
Click to Show 3D Structure of This Binding Site
set background white;style ions nothing; color 8e8e8e;style chemicals nothing; select .GDP or .GDP2 or .GDP3 or :3GDP;style chemicals stick;color identity;select .A:11 or .A:12 or .A:13 or .A:14 or .A:15 or .A:16 or .A:17 or .A:18 or .A:28 or .A:29 or .A:30 or .A:31 or .A:32 or .A:34 or .A:57 or .A:116 or .A:117 or .A:118 or .A:119 or .A:120 or .A:144 or .A:145 or .A:146 or .A:147; color #f3c393; zoom selection;set surface opacity 0.5;set surface Van der Waals surface;set mode all
|
ALA11
3.878
CYS12
3.961
GLY13
2.893
VAL14
3.423
GLY15
3.070
LYS16
2.789
SER17
2.985
ALA18
2.821
PHE28
3.390
VAL29
4.696
ASP30
2.838
GLU31
4.715
|
|||||
PDB ID: 6P8Z Crystal structure of human KRAS G12C covalently bound to an acryloylazetidine acetamide inhibitor | ||||||
Method | X-ray diffraction | Resolution | 1.65 Å | Mutation | Yes | [4] |
PDB Sequence |
GMTEYKLVVV
9 GACGVGKSAL19 TIQLIQNHFV29 DEYDPTIEDS39 YRKQVVIDGE49 TSLLDILDTA 59 GQAMRDQYMR73 TGEGFLLVFA83 INNTKSFEDI93 HHYREQIKRV103 KDSEDVPMVL 113 VGNKSDLPSR123 TVDTKQAQDL133 ARSYGIPFIE143 TSAKTRQGVD153 DAFYTLVREI 163 RKHKE
|
|||||
Click to Show 3D Structure of This Binding Site
set background white;style ions nothing; color 8e8e8e;style chemicals nothing; select .GDP or .GDP2 or .GDP3 or :3GDP;style chemicals stick;color identity;select .A:11 or .A:12 or .A:13 or .A:14 or .A:15 or .A:16 or .A:17 or .A:18 or .A:28 or .A:29 or .A:30 or .A:31 or .A:32 or .A:57 or .A:116 or .A:117 or .A:118 or .A:119 or .A:120 or .A:144 or .A:145 or .A:146 or .A:147; color #00ffc7; zoom selection;set surface opacity 0.5;set surface Van der Waals surface;set mode all
|
ALA11
3.722
CYS12
3.832
GLY13
2.758
VAL14
3.232
GLY15
2.953
LYS16
2.843
SER17
3.079
ALA18
2.811
PHE28
3.103
VAL29
3.002
ASP30
2.558
GLU31
4.139
|
|||||
PDB ID: 6P8W Crystal structure of human KRAS G12C covalently bound to an acryloylazetidine acetamide inhibitor. | ||||||
Method | X-ray diffraction | Resolution | 2.10 Å | Mutation | Yes | [4] |
PDB Sequence |
GMTEYKLVVV
9 GACGVGKSAL19 TIQLIQNHFV29 DEYDPTIEDS39 YRKQVVIDGE49 TSLLDILDTA 59 GQEEYSAMRD69 QYMRTGEGFL79 LVFAINNTKS89 FEDIHHYREQ99 IKRVKDSEDV 109 PMVLVGNKSD119 LPSRTVDTKQ129 AQDLARSYGI139 PFIETSAKTR149 QGVDDAFYTL 159 VREIRKHKE
|
|||||
Click to Show 3D Structure of This Binding Site
set background white;style ions nothing; color 8e8e8e;style chemicals nothing; select .GDP or .GDP2 or .GDP3 or :3GDP;style chemicals stick;color identity;select .A:11 or .A:12 or .A:13 or .A:14 or .A:15 or .A:16 or .A:17 or .A:18 or .A:28 or .A:29 or .A:30 or .A:31 or .A:32 or .A:116 or .A:117 or .A:118 or .A:119 or .A:120 or .A:144 or .A:145 or .A:146 or .A:147; color #f3c393; zoom selection;set surface opacity 0.5;set surface Van der Waals surface;set mode all
|
ALA11
3.893
CYS12
3.937
GLY13
2.816
VAL14
3.425
GLY15
3.035
LYS16
2.747
SER17
3.066
ALA18
2.860
PHE28
3.209
VAL29
3.557
ASP30
2.655
|
|||||
PDB ID: 6P8X Crystal structure of human KRAS G12C covalently bound to an acryloylazetidine acetamide inhibitor. | ||||||
Method | X-ray diffraction | Resolution | 2.11 Å | Mutation | Yes | [4] |
PDB Sequence |
TEYKLVVVGA
11 CGVGKSALTI21 QLIQNHFVDE31 YDPTIEDSYR41 KQVVIDGETS51 LLDILDTAGQ 61 EEYSAMRDQY71 MRTGEGFLLV81 FAINNTKSFE91 DIHHYREQIK101 RVKDSEDVPM 111 VLVGNKSDLP121 SRTVDTKQAQ131 DLARSYGIPF141 IETSAKTRQG151 VDDAFYTLVR 161 EIRKHK
|
|||||
Click to Show 3D Structure of This Binding Site
set background white;style ions nothing; color 8e8e8e;style chemicals nothing; select .GDP or .GDP2 or .GDP3 or :3GDP;style chemicals stick;color identity;select .A:11 or .A:12 or .A:13 or .A:14 or .A:15 or .A:16 or .A:17 or .A:18 or .A:28 or .A:29 or .A:30 or .A:31 or .A:32 or .A:116 or .A:117 or .A:118 or .A:119 or .A:120 or .A:144 or .A:145 or .A:146 or .A:147; color #00ffc7; zoom selection;set surface opacity 0.5;set surface Van der Waals surface;set mode all
|
ALA11
3.858
CYS12
4.018
GLY13
2.982
VAL14
3.363
GLY15
3.075
LYS16
2.794
SER17
3.030
ALA18
2.864
PHE28
3.221
VAL29
2.906
ASP30
2.600
|
|||||
PDB ID: 6P8Y Crystal structure of human KRAS G12C covalently bound to an acryloylazetidine acetamide inhibitor. | ||||||
Method | X-ray diffraction | Resolution | 2.31 Å | Mutation | Yes | [4] |
PDB Sequence |
MTEYKLVVVG
10 ACGVGKSALT20 IQLIQNHFVD30 EYDPTIEDSY40 RKQVVIDGET50 SLLDILDTAG 60 QEEYSAMRDQ70 YMRTGEGFLL80 VFAINNTKSF90 EDIHHYREQI100 KRVKDSEDVP 110 MVLVGNKSDL120 PSRTVDTKQA130 QDLARSYGIP140 FIETSAKTRQ150 GVDDAFYTLV 160 REIRKH
|
|||||
Click to Show 3D Structure of This Binding Site
set background white;style ions nothing; color 8e8e8e;style chemicals nothing; select .GDP or .GDP2 or .GDP3 or :3GDP;style chemicals stick;color identity;select .A:11 or .A:12 or .A:13 or .A:14 or .A:15 or .A:16 or .A:17 or .A:18 or .A:28 or .A:29 or .A:32 or .A:34 or .A:57 or .A:116 or .A:117 or .A:119 or .A:120 or .A:144 or .A:145 or .A:146 or .A:147; color #f3c393; zoom selection;set surface opacity 0.5;set surface Van der Waals surface;set mode all
|
ALA11
3.836
CYS12
4.262
GLY13
3.239
VAL14
3.452
GLY15
3.141
LYS16
2.719
SER17
2.903
ALA18
2.771
PHE28
3.574
VAL29
4.477
TYR32
3.444
|
|||||
PDB ID: 7RP3 Crystal structure of GNE-1952 alkylated KRAS G12C in complex with 2H11 CLAMP | ||||||
Method | X-ray diffraction | Resolution | 2.00 Å | Mutation | Yes | [5] |
PDB Sequence |
STEYKLVVVG
10 ACGVGKSALT20 IQLIQNHFVD30 EYDPTIEDSY40 RKQVVIDGET50 CLLDILDTAG 60 QEEYSAMRDQ70 YMRTGEGFLC80 VFAINNTKSF90 EDIHHYREQI100 KRVKDSEDVP 110 MVLVGNKCDL120 PSRTVDTKQA130 QDLARSYGIP140 FIETSAKTRQ150 GVDDAFYTLV 160 REIRKHK
|
|||||
Click to Show 3D Structure of This Binding Site
set background white;style ions nothing; color 8e8e8e;style chemicals nothing; select .GDP or .GDP2 or .GDP3 or :3GDP;style chemicals stick;color identity;select .A:11 or .A:12 or .A:13 or .A:14 or .A:15 or .A:16 or .A:17 or .A:18 or .A:19 or .A:28 or .A:29 or .A:30 or .A:31 or .A:32 or .A:34 or .A:57 or .A:116 or .A:117 or .A:118 or .A:119 or .A:120 or .A:144 or .A:145 or .A:146 or .A:147; color #00ffc7; zoom selection;set surface opacity 0.5;set surface Van der Waals surface;set mode all
|
ALA11
3.716
CYS12
3.796
GLY13
2.829
VAL14
3.508
GLY15
2.963
LYS16
2.509
SER17
2.941
ALA18
2.784
LEU19
4.939
PHE28
3.436
VAL29
2.929
ASP30
2.661
GLU31
3.897
|
|||||
PDB ID: 8AFB CRYSTAL STRUCTURE OF KRAS-G12C IN COMPLEX WITH COMPOUND 23 (BI-0474) | ||||||
Method | X-ray diffraction | Resolution | 1.12 Å | Mutation | Yes | [6] |
PDB Sequence |
TEYKLVVVGA
11 CGVGKSALTI21 QLIQNHFVDE31 YDPTIEDSYR41 KQVVIDGETC51 LLDILDTAGQ 61 EEYSAMRDQY71 MRTGEGFLCV81 FAINNTKSFE91 DIHHYREQIK101 RVKDSEDVPM 111 VLVGNKSDLP121 SRTVDTKQAQ131 DLARSYGIPF141 IETSAKTRQG151 VDDAFYTLVR 161 EIRK
|
|||||
Click to Show 3D Structure of This Binding Site
set background white;style ions nothing; color 8e8e8e;style chemicals nothing; select .GDP or .GDP2 or .GDP3 or :3GDP;style chemicals stick;color identity;select .A:11 or .A:12 or .A:13 or .A:14 or .A:15 or .A:16 or .A:17 or .A:18 or .A:28 or .A:29 or .A:30 or .A:31 or .A:32 or .A:34 or .A:57 or .A:116 or .A:117 or .A:118 or .A:119 or .A:120 or .A:144 or .A:145 or .A:146 or .A:147; color #f3c393; zoom selection;set surface opacity 0.5;set surface Van der Waals surface;set mode all
|
ALA11
3.830
CYS12
3.663
GLY13
2.764
VAL14
3.355
GLY15
3.006
LYS16
2.782
SER17
2.931
ALA18
2.887
PHE28
4.030
VAL29
4.969
ASP30
2.686
GLU31
4.674
|
|||||
PDB ID: 4LDJ Crystal Structure of a GDP-bound G12C Oncogenic Mutant of Human GTPase KRas | ||||||
Method | X-ray diffraction | Resolution | 1.15 Å | Mutation | Yes | [7] |
PDB Sequence |
GMTEYKLVVV
9 GACGVGKSAL19 TIQLIQNHFV29 DEYDPTIEDS39 YRKQVVIDGE49 TCLLDILDTA 59 GQEEYSAMRD69 QYMRTGEGFL79 CVFAINNTKS89 FEDIHHYREQ99 IKRVKDSEDV 109 PMVLVGNKCD119 LPSRTVDTKQ129 AQDLARSYGI139 PFIETSAKTR149 QGVDDAFYTL 159 VREIRKHKEK169
|
|||||
Click to Show 3D Structure of This Binding Site
set background white;style ions nothing; color 8e8e8e;style chemicals nothing; select .GDP or .GDP2 or .GDP3 or :3GDP;style chemicals stick;color identity;select .A:11 or .A:12 or .A:13 or .A:14 or .A:15 or .A:16 or .A:17 or .A:18 or .A:19 or .A:28 or .A:29 or .A:30 or .A:31 or .A:32 or .A:34 or .A:57 or .A:116 or .A:117 or .A:118 or .A:119 or .A:120 or .A:144 or .A:145 or .A:146 or .A:147 or .A:148; color #00ffc7; zoom selection;set surface opacity 0.5;set surface Van der Waals surface;set mode all
|
ALA11
3.824
CYS12
3.124
GLY13
1.952
VAL14
2.799
GLY15
2.235
LYS16
1.931
SER17
2.136
ALA18
2.065
LEU19
4.599
PHE28
3.126
VAL29
4.337
ASP30
1.865
GLU31
3.858
|
|||||
PDB ID: 6TAN X-RAY STRUCTURE OF HUMAN K-RAS G12C IN COMPLEX WITH COVALENT ISOQUINOLINONE INHIBITOR (COMPOUND 17) | ||||||
Method | X-ray diffraction | Resolution | 1.16 Å | Mutation | Yes | [8] |
PDB Sequence |
GMTEYKLVVV
9 GACGVGKSAL19 TIQLIQNHFV29 DEYDPTIEDS39 YRKQVVIDGE49 TSLLDILDTA 59 GQEEYSAMRD69 QYMRTGEGFL79 LVFAINNTKS89 FEDIHHYREQ99 IKRVKDSEDV 109 PMVLVGNKSD119 LPSRTVDTKQ129 AQDLARSYGI139 PFIETSAKTR149 QGVDDAFYTL 159 VREIRKHKEK169
|
|||||
Click to Show 3D Structure of This Binding Site
set background white;style ions nothing; color 8e8e8e;style chemicals nothing; select .GDP or .GDP2 or .GDP3 or :3GDP;style chemicals stick;color identity;select .A:11 or .A:12 or .A:13 or .A:14 or .A:15 or .A:16 or .A:17 or .A:18 or .A:28 or .A:29 or .A:30 or .A:31 or .A:32 or .A:34 or .A:57 or .A:116 or .A:117 or .A:118 or .A:119 or .A:120 or .A:144 or .A:145 or .A:146 or .A:147; color #f3c393; zoom selection;set surface opacity 0.5;set surface Van der Waals surface;set mode all
|
ALA11
3.919
CYS12
3.880
GLY13
2.840
VAL14
3.349
GLY15
3.041
LYS16
2.787
SER17
2.941
ALA18
2.853
PHE28
3.592
VAL29
4.731
ASP30
2.767
GLU31
4.707
|
|||||
PDB ID: 7O70 KRasG12C ligand complex | ||||||
Method | X-ray diffraction | Resolution | 1.18 Å | Mutation | Yes | [9] |
PDB Sequence |
GMTEYKLVVV
9 GACGVGKSAL19 TIQLIQNHFV29 DEYDPTIEDS39 YRKQVVIDGE49 TSLLDILDTA 59 GQEEYSAMRD69 QYMRTGEGFL79 LVFAINNTKS89 FEDIHHYREQ99 IKRVKDSEDV 109 PMVLVGNKSD119 LPSRTVDTKQ129 AQDLARSYGI139 PFIETSAKTR149 QGVDDAFYTL 159 VREIRKHK
|
|||||
Click to Show 3D Structure of This Binding Site
set background white;style ions nothing; color 8e8e8e;style chemicals nothing; select .GDP or .GDP2 or .GDP3 or :3GDP;style chemicals stick;color identity;select .A:11 or .A:12 or .A:13 or .A:14 or .A:15 or .A:16 or .A:17 or .A:18 or .A:19 or .A:28 or .A:29 or .A:30 or .A:31 or .A:32 or .A:34 or .A:57 or .A:116 or .A:117 or .A:118 or .A:119 or .A:120 or .A:144 or .A:145 or .A:146 or .A:147; color #00ffc7; zoom selection;set surface opacity 0.5;set surface Van der Waals surface;set mode all
|
ALA11
3.770
CYS12
3.877
GLY13
2.840
VAL14
3.345
GLY15
3.072
LYS16
2.811
SER17
3.070
ALA18
2.761
LEU19
4.993
PHE28
3.125
VAL29
2.881
ASP30
2.699
GLU31
4.716
|
|||||
PDB ID: 7R0N KRasG12C in complex with GDP and compound 2 | ||||||
Method | X-ray diffraction | Resolution | 1.20 Å | Mutation | Yes | [10] |
PDB Sequence |
GMTEYKLVVV
9 GACGVGKSAL19 TIQLIQNHFV29 DEYDPTIEDS39 YRKQVVIDGE49 TSLLDILDTA 59 GQEEYSAMRD69 QYMRTGEGFL79 LVFAINNTKS89 FEDIHHYREQ99 IKRVKDVPMV 112 LVGNKSDLPS122 RTVDTKQAQD132 LARSYGIPFI142 ETSAKTRQGV152 DDAFYTLVRE 162 IRKHKEK
|
|||||
Click to Show 3D Structure of This Binding Site
set background white;style ions nothing; color 8e8e8e;style chemicals nothing; select .GDP or .GDP2 or .GDP3 or :3GDP;style chemicals stick;color identity;select .A:11 or .A:12 or .A:13 or .A:14 or .A:15 or .A:16 or .A:17 or .A:18 or .A:28 or .A:29 or .A:30 or .A:31 or .A:32 or .A:34 or .A:57 or .A:116 or .A:117 or .A:118 or .A:119 or .A:120 or .A:144 or .A:145 or .A:146 or .A:147; color #f3c393; zoom selection;set surface opacity 0.5;set surface Van der Waals surface;set mode all
|
ALA11
3.844
CYS12
3.946
GLY13
2.860
VAL14
3.388
GLY15
3.088
LYS16
2.785
SER17
3.019
ALA18
2.852
PHE28
3.520
VAL29
4.851
ASP30
2.791
GLU31
4.767
|
|||||
PDB ID: 4LUC Crystal Structure of small molecule disulfide 6 bound to K-Ras G12C | ||||||
Method | X-ray diffraction | Resolution | 1.29 Å | Mutation | Yes | [11] |
PDB Sequence |
MTEYKLVVVG
10 ACGVGKSALT20 IQLIQNHFVD30 EYDPTIEDSY40 RKQVVIDGET50 SLLDILDTAG 60 QEEYSAMRDQ70 YMRTGEGFLL80 VFAINNTKSF90 EDIHHYREQI100 KRVKDSEDVP 110 MVLVGNKSDL120 PSRTVDTKQA130 QDLARSYGIP140 FIETSAKTRQ150 GVDDAFYTLV 160 REIRKHKE
|
|||||
Click to Show 3D Structure of This Binding Site
set background white;style ions nothing; color 8e8e8e;style chemicals nothing; select .GDP or .GDP2 or .GDP3 or :3GDP;style chemicals stick;color identity;select .A:11 or .A:12 or .A:13 or .A:14 or .A:15 or .A:16 or .A:17 or .A:18 or .A:19 or .A:28 or .A:29 or .A:30 or .A:31 or .A:32 or .A:34 or .A:57 or .A:116 or .A:117 or .A:118 or .A:119 or .A:120 or .A:144 or .A:145 or .A:146 or .A:147 or .A:148; color #00ffc7; zoom selection;set surface opacity 0.5;set surface Van der Waals surface;set mode all
|
ALA11
3.793
CYS12
3.502
GLY13
2.026
VAL14
2.794
GLY15
2.241
LYS16
2.000
SER17
2.179
ALA18
1.934
LEU19
4.449
PHE28
2.709
VAL29
2.241
ASP30
1.867
GLU31
3.803
|
|||||
PDB ID: 6B0V Crystal Structure of small molecule ARS-107 covalently bound to K-Ras G12C | ||||||
Method | X-ray diffraction | Resolution | 1.29 Å | Mutation | Yes | [12] |
PDB Sequence |
MTEYKLVVVG
10 ACGVGKSALT20 IQLIQNHFVD30 EYDPTIEDSY40 RKQVVIDGET50 SLLDILDTAG 60 QEEYSAMRDQ70 YMRTGEGFLL80 VFAINNTKSF90 EDIHHYREQI100 KRVKDSEDVP 110 MVLVGNKSDL120 PSRTVDTKQA130 QDLARSYGIP140 FIETSAKTRQ150 GVDDAFYTLV 160 REIRKHK
|
|||||
Click to Show 3D Structure of This Binding Site
set background white;style ions nothing; color 8e8e8e;style chemicals nothing; select .GDP or .GDP2 or .GDP3 or :3GDP;style chemicals stick;color identity;select .A:11 or .A:12 or .A:13 or .A:14 or .A:15 or .A:16 or .A:17 or .A:18 or .A:28 or .A:29 or .A:30 or .A:31 or .A:32 or .A:57 or .A:116 or .A:117 or .A:118 or .A:119 or .A:120 or .A:144 or .A:145 or .A:146 or .A:147; color #f3c393; zoom selection;set surface opacity 0.5;set surface Van der Waals surface;set mode all
|
ALA11
3.806
CYS12
3.804
GLY13
2.745
VAL14
3.344
GLY15
3.022
LYS16
2.759
SER17
2.982
ALA18
2.760
PHE28
3.072
VAL29
2.876
ASP30
2.786
GLU31
4.823
|
|||||
PDB ID: 7A1X KRASG12C GDP form in complex with Cpd1 | ||||||
Method | X-ray diffraction | Resolution | 1.32 Å | Mutation | Yes | [13] |
PDB Sequence |
GMTEYKLVVV
9 GACGVGKSAL19 TIQLIQNHFV29 DEYDPTIEDS39 YRKQVVIDGE49 TCLLDILDTA 59 GQEEYSAMRD69 QYMRTGEGFL79 CVFAINNTKS89 FEDIHHYREQ99 IKRVKDSEDV 109 PMVLVGNKCD119 LPSRTVDTKQ129 AQDLARSYGI139 PFIETSAKTR149 QGVDDAFYTL 159 VREIRKHKEK169
|
|||||
Click to Show 3D Structure of This Binding Site
set background white;style ions nothing; color 8e8e8e;style chemicals nothing; select .GDP or .GDP2 or .GDP3 or :3GDP;style chemicals stick;color identity;select .A:11 or .A:12 or .A:13 or .A:14 or .A:15 or .A:16 or .A:17 or .A:18 or .A:28 or .A:29 or .A:30 or .A:31 or .A:32 or .A:34 or .A:57 or .A:116 or .A:117 or .A:118 or .A:119 or .A:120 or .A:144 or .A:145 or .A:146 or .A:147; color #00ffc7; zoom selection;set surface opacity 0.5;set surface Van der Waals surface;set mode all
|
ALA11
3.831
CYS12
3.759
GLY13
2.784
VAL14
3.343
GLY15
2.995
LYS16
2.779
SER17
2.950
ALA18
2.853
PHE28
3.808
VAL29
4.777
ASP30
2.670
GLU31
4.594
|
|||||
PDB ID: 4LYH Crystal Structure of small molecule vinylsulfonamide 9 covalently bound to K-Ras G12C | ||||||
Method | X-ray diffraction | Resolution | 1.37 Å | Mutation | Yes | [11] |
PDB Sequence |
MTEYKLVVVG
10 ACGVGKSALT20 IQLIQNHFVD30 IEDSYRKQVV45 IDGETSLLDI55 LDTAGQEEYS 65 AMRDQYMRTG75 EGFLLVFAIN85 NTKSFEDIHH95 YREQIKRVKD105 SEDVPMVLVG 115 NKSDLPSRTV125 DTKQAQDLAR135 SYGIPFIETS145 AKTRQGVDDA155 FYTLVREIRK 165 HKE
|
|||||
Click to Show 3D Structure of This Binding Site
set background white;style ions nothing; color 8e8e8e;style chemicals nothing; select .GDP or .GDP2 or .GDP3 or :3GDP;style chemicals stick;color identity;select .A:11 or .A:12 or .A:13 or .A:14 or .A:15 or .A:16 or .A:17 or .A:18 or .A:19 or .A:28 or .A:29 or .A:30 or .A:36 or .A:38 or .A:57 or .A:116 or .A:117 or .A:118 or .A:119 or .A:120 or .A:144 or .A:145 or .A:146 or .A:147 or .A:148; color #f3c393; zoom selection;set surface opacity 0.5;set surface Van der Waals surface;set mode all
|
ALA11
3.770
CYS12
3.162
GLY13
1.946
VAL14
2.881
GLY15
2.276
LYS16
1.918
SER17
2.094
ALA18
2.096
LEU19
4.689
PHE28
2.952
VAL29
2.942
ASP30
2.330
ILE36
4.981
|
|||||
PDB ID: 6T5B KRasG12C ligand complex | ||||||
Method | X-ray diffraction | Resolution | 1.37 Å | Mutation | Yes | [14] |
PDB Sequence |
GMTEYKLVVV
9 GACGVGKSAL19 TIQLIQNHFV29 DEYDPTIEDS39 YRKQVVIDGE49 TSLLDILDTA 59 GQEEYSAMRD69 QYMRTGEGFL79 LVFAINNTKS89 FEDIHHYREQ99 IKRVKDSEDV 109 PMVLVGNKSD119 LPSRTVDTKQ129 AQDLARSYGI139 PFIETSAKTR149 QGVDDAFYTL 159 IREIRKHKEK169
|
|||||
Click to Show 3D Structure of This Binding Site
set background white;style ions nothing; color 8e8e8e;style chemicals nothing; select .GDP or .GDP2 or .GDP3 or :3GDP;style chemicals stick;color identity;select .A:11 or .A:12 or .A:13 or .A:14 or .A:15 or .A:16 or .A:17 or .A:18 or .A:28 or .A:29 or .A:30 or .A:31 or .A:32 or .A:34 or .A:57 or .A:116 or .A:117 or .A:118 or .A:119 or .A:120 or .A:144 or .A:145 or .A:146 or .A:147; color #00ffc7; zoom selection;set surface opacity 0.5;set surface Van der Waals surface;set mode all
|
ALA11
3.753
CYS12
3.906
GLY13
2.888
VAL14
3.286
GLY15
2.947
LYS16
2.809
SER17
2.996
ALA18
2.761
PHE28
3.574
VAL29
4.513
ASP30
3.107
GLU31
2.888
|
|||||
PDB ID: 5V9U Crystal Structure of small molecule ARS-1620 covalently bound to K-Ras G12C | ||||||
Method | X-ray diffraction | Resolution | 1.38 Å | Mutation | Yes | [15] |
PDB Sequence |
MTEYKLVVVG
10 ACGVGKSALT20 IQLIQNHFVD30 EYDPTIEDSY40 RKQVVIDGET50 SLLDILDTAG 60 QEEYSAMRDQ70 YMRTGEGFLL80 VFAINNTKSF90 EDIHHYREQI100 KRVKDSEDVP 110 MVLVGNKSDL120 PSRTVDTKQA130 QDLARSYGIP140 FIETSAKTRQ150 GVDDAFYTLV 160 REIRKHKEK
|
|||||
Click to Show 3D Structure of This Binding Site
set background white;style ions nothing; color 8e8e8e;style chemicals nothing; select .GDP or .GDP2 or .GDP3 or :3GDP;style chemicals stick;color identity;select .A:11 or .A:12 or .A:13 or .A:14 or .A:15 or .A:16 or .A:17 or .A:18 or .A:28 or .A:29 or .A:30 or .A:31 or .A:32 or .A:34 or .A:57 or .A:116 or .A:117 or .A:118 or .A:119 or .A:120 or .A:144 or .A:145 or .A:146 or .A:147; color #f3c393; zoom selection;set surface opacity 0.5;set surface Van der Waals surface;set mode all
|
ALA11
3.747
CYS12
3.824
GLY13
2.809
VAL14
3.245
GLY15
2.949
LYS16
2.793
SER17
3.009
ALA18
2.819
PHE28
3.227
VAL29
2.749
ASP30
2.699
GLU31
4.301
|
|||||
PDB ID: 5F2E Crystal Structure of small molecule ARS-853 covalently bound to K-Ras G12C | ||||||
Method | X-ray diffraction | Resolution | 1.40 Å | Mutation | Yes | [16] |
PDB Sequence |
GMTEYKLVVV
9 GACGVGKSAL19 TIQLIQNHFV29 DEYDPTIEDS39 YRKQVVIDGE49 TSLLDILDTA 59 GQEEYSAMRD69 QYMRTGEGFL79 LVFAINNTKS89 FEDIHHYREQ99 IKRVKDSEDV 109 PMVLVGNKSD119 LPSRTVDTKQ129 AQDLARSYGI139 PFIETSAKTR149 QGVDDAFYTL 159 VREIRKHK
|
|||||
Click to Show 3D Structure of This Binding Site
set background white;style ions nothing; color 8e8e8e;style chemicals nothing; select .GDP or .GDP2 or .GDP3 or :3GDP;style chemicals stick;color identity;select .A:11 or .A:12 or .A:13 or .A:14 or .A:15 or .A:16 or .A:17 or .A:18 or .A:28 or .A:29 or .A:30 or .A:31 or .A:32 or .A:34 or .A:57 or .A:116 or .A:117 or .A:118 or .A:119 or .A:120 or .A:144 or .A:145 or .A:146 or .A:147; color #00ffc7; zoom selection;set surface opacity 0.5;set surface Van der Waals surface;set mode all
|
ALA11
3.722
CYS12
3.846
GLY13
2.771
VAL14
3.306
GLY15
2.986
LYS16
2.761
SER17
2.941
ALA18
2.871
PHE28
3.112
VAL29
3.268
ASP30
2.924
GLU31
4.674
|
|||||
PDB ID: 6B0Y Crystal Structure of small molecule ARS-917 covalently bound to K-Ras G12C | ||||||
Method | X-ray diffraction | Resolution | 1.43 Å | Mutation | Yes | [12] |
PDB Sequence |
MTEYKLVVVG
10 ACGVGKSALT20 IQLIQNHFVD30 EYDPTIEDSY40 RKQVVIDGET50 SLLDILDTAG 60 QEEYSAMRDQ70 YMRTGEGFLL80 VFAINNTKSF90 EDIHHYREQI100 KRVKDSEDVP 110 MVLVGNKSDL120 PSRTVDTKQA130 QDLARSYGIP140 FIETSAKTRQ150 GVDDAFYTLV 160 REIRKHKE
|
|||||
Click to Show 3D Structure of This Binding Site
set background white;style ions nothing; color 8e8e8e;style chemicals nothing; select .GDP or .GDP2 or .GDP3 or :3GDP;style chemicals stick;color identity;select .A:11 or .A:12 or .A:13 or .A:14 or .A:15 or .A:16 or .A:17 or .A:18 or .A:28 or .A:29 or .A:30 or .A:31 or .A:32 or .A:34 or .A:57 or .A:116 or .A:117 or .A:118 or .A:119 or .A:120 or .A:144 or .A:145 or .A:146 or .A:147; color #f3c393; zoom selection;set surface opacity 0.5;set surface Van der Waals surface;set mode all
|
ALA11
3.747
CYS12
3.821
GLY13
2.810
VAL14
3.212
GLY15
2.966
LYS16
2.820
SER17
2.979
ALA18
2.793
PHE28
3.198
VAL29
2.873
ASP30
2.733
GLU31
4.459
|
|||||
PDB ID: 4M1Y Crystal Structure of small molecule vinylsulfonamide 15 covalently bound to K-Ras G12C | ||||||
Method | X-ray diffraction | Resolution | 1.49 Å | Mutation | Yes | [11] |
PDB Sequence |
MTEYKLVVVG
10 ACGVGKSALT20 IQLIQNHFVD30 EEDSYRKQVV45 IDGETSLLDI55 LDTAGEEYSA 66 MRDQYMRTGE76 GFLLVFAINN86 TKSFEDIHHY96 REQIKRVKDS106 EDVPMVLVGN 116 KSDLPSRTVD126 TKQAQDLARS136 YGIPFIETSA146 KTRQGVDDAF156 YTLVREIRKH 166 KE
|
|||||
Click to Show 3D Structure of This Binding Site
set background white;style ions nothing; color 8e8e8e;style chemicals nothing; select .GDP or .GDP2 or .GDP3 or :3GDP;style chemicals stick;color identity;select .A:11 or .A:12 or .A:13 or .A:14 or .A:15 or .A:16 or .A:17 or .A:18 or .A:19 or .A:28 or .A:29 or .A:30 or .A:31 or .A:57 or .A:116 or .A:117 or .A:118 or .A:119 or .A:120 or .A:144 or .A:145 or .A:146 or .A:147 or .A:148; color #00ffc7; zoom selection;set surface opacity 0.5;set surface Van der Waals surface;set mode all
|
ALA11
3.837
CYS12
3.220
GLY13
1.980
VAL14
2.880
GLY15
2.188
LYS16
1.870
SER17
2.098
ALA18
2.064
LEU19
4.651
PHE28
2.970
VAL29
2.769
ASP30
2.527
|
|||||
PDB ID: 4LV6 Crystal Structure of small molecule disulfide 4 covalently bound to K-Ras G12C | ||||||
Method | X-ray diffraction | Resolution | 1.50 Å | Mutation | Yes | [11] |
PDB Sequence |
MTEYKLVVVG
10 ACGVGKSALT20 IQLIQNHFVD30 EYDPTIEDSY40 RKQVVIDGET50 SLLDILDTAG 60 QEEYSAMRDQ70 YMRTGEGFLL80 VFAINNTKSF90 EDIHHYREQI100 KRVKDSEDVP 110 MVLVGNKSDL120 PSRTVDTKQA130 QDLARSYGIP140 FIETSAKTRQ150 GVDDAFYTLV 160 REIRKHKE
|
|||||
Click to Show 3D Structure of This Binding Site
set background white;style ions nothing; color 8e8e8e;style chemicals nothing; select .GDP or .GDP2 or .GDP3 or :3GDP;style chemicals stick;color identity;select .A:11 or .A:12 or .A:13 or .A:14 or .A:15 or .A:16 or .A:17 or .A:18 or .A:19 or .A:28 or .A:29 or .A:30 or .A:31 or .A:32 or .A:34 or .A:57 or .A:116 or .A:117 or .A:118 or .A:119 or .A:120 or .A:144 or .A:145 or .A:146 or .A:147 or .A:148; color #f3c393; zoom selection;set surface opacity 0.5;set surface Van der Waals surface;set mode all
|
ALA11
3.719
CYS12
3.504
GLY13
2.074
VAL14
2.822
GLY15
2.229
LYS16
1.883
SER17
2.216
ALA18
1.977
LEU19
4.546
PHE28
2.746
VAL29
2.486
ASP30
1.840
GLU31
3.831
|
|||||
PDB ID: 4L8G Crystal Structure of K-Ras G12C, GDP-bound | ||||||
Method | X-ray diffraction | Resolution | 1.52 Å | Mutation | Yes | [11] |
PDB Sequence |
MTEYKLVVVG
10 ACGVGKSALT20 IQLIQNHFVD30 EYDPTIEDSY40 RKQVVIDGET50 CLLDILDTAQ 70 YMRTGEGFLC80 VFAINNTKSF90 EDIHHYREQI100 KRVKDSEDVP110 MVLVGNKCDL 120 PSRTVDTKQA130 QDLARSYGIP140 FIETSAKTRQ150 GVDDAFYTLV160 REIRKHK |
|||||
Click to Show 3D Structure of This Binding Site
set background white;style ions nothing; color 8e8e8e;style chemicals nothing; select .GDP or .GDP2 or .GDP3 or :3GDP;style chemicals stick;color identity;select .A:11 or .A:12 or .A:13 or .A:14 or .A:15 or .A:16 or .A:17 or .A:18 or .A:19 or .A:28 or .A:29 or .A:30 or .A:31 or .A:32 or .A:34 or .A:57 or .A:116 or .A:117 or .A:118 or .A:119 or .A:120 or .A:144 or .A:145 or .A:146 or .A:147 or .A:148; color #00ffc7; zoom selection;set surface opacity 0.5;set surface Van der Waals surface;set mode all
|
ALA11
3.784
CYS12
3.032
GLY13
1.971
VAL14
2.759
GLY15
2.278
LYS16
1.916
SER17
2.141
ALA18
2.046
LEU19
4.564
PHE28
2.765
VAL29
2.149
ASP30
1.871
GLU31
2.825
|
|||||
PDB ID: 4M1S Crystal Structure of small molecule vinylsulfonamide 13 covalently bound to K-Ras G12C | ||||||
Method | X-ray diffraction | Resolution | 1.55 Å | Mutation | Yes | [11] |
PDB Sequence |
MTEYKLVVVG
10 ACGVGKSALT20 IQLIQNHFVD30 EDSYRKQVVI46 DGETSLLDIL56 DTAGQEEYSA 66 MRDQYMRTGE76 GFLLVFAINN86 TKSFEDIHHY96 REQIKRVKDS106 EDVPMVLVGN 116 KSDLPSRTVD126 TKQAQDLARS136 YGIPFIETSA146 KTRQGVDDAF156 YTLVREIRKH 166 K
|
|||||
Click to Show 3D Structure of This Binding Site
set background white;style ions nothing; color 8e8e8e;style chemicals nothing; select .GDP or .GDP2 or .GDP3 or :3GDP;style chemicals stick;color identity;select .A:11 or .A:12 or .A:13 or .A:14 or .A:15 or .A:16 or .A:17 or .A:18 or .A:19 or .A:28 or .A:29 or .A:30 or .A:57 or .A:116 or .A:117 or .A:118 or .A:119 or .A:120 or .A:144 or .A:145 or .A:146 or .A:147; color #f3c393; zoom selection;set surface opacity 0.5;set surface Van der Waals surface;set mode all
|
ALA11
3.854
CYS12
3.231
GLY13
1.967
VAL14
2.881
GLY15
2.231
LYS16
1.962
SER17
2.065
ALA18
2.025
LEU19
4.693
PHE28
3.015
VAL29
3.078
|
|||||
PDB ID: 4LYF Crystal Structure of small molecule vinylsulfonamide 8 covalently bound to K-Ras G12C | ||||||
Method | X-ray diffraction | Resolution | 1.57 Å | Mutation | Yes | [11] |
PDB Sequence |
MTEYKLVVVG
10 ACGVGKSALT20 IQLIQNHFVD30 EDSYRKQVVI46 DGETSLLDIL56 DTAGQEEYSA 66 MRDQYMRTGE76 GFLLVFAINN86 TKSFEDIHHY96 REQIKRVKDS106 EDVPMVLVGN 116 KSDLPSRTVD126 TKQAQDLARS136 YGIPFIETSA146 KTRQGVDDAF156 YTLVREIRKH 166 K
|
|||||
Click to Show 3D Structure of This Binding Site
set background white;style ions nothing; color 8e8e8e;style chemicals nothing; select .GDP or .GDP2 or .GDP3 or :3GDP;style chemicals stick;color identity;select .A:11 or .A:12 or .A:13 or .A:14 or .A:15 or .A:16 or .A:17 or .A:18 or .A:19 or .A:28 or .A:29 or .A:30 or .A:38 or .A:57 or .A:116 or .A:117 or .A:118 or .A:119 or .A:120 or .A:144 or .A:145 or .A:146 or .A:147; color #00ffc7; zoom selection;set surface opacity 0.5;set surface Van der Waals surface;set mode all
|
ALA11
3.864
CYS12
3.271
GLY13
1.988
VAL14
2.862
GLY15
2.210
LYS16
1.904
SER17
2.124
ALA18
2.052
LEU19
4.676
PHE28
2.951
VAL29
2.892
ASP30
2.757
|
|||||
PDB ID: 4M1O Crystal Structure of small molecule vinylsulfonamide 7 covalently bound to K-Ras G12C | ||||||
Method | X-ray diffraction | Resolution | 1.57 Å | Mutation | Yes | [11] |
PDB Sequence |
MTEYKLVVVG
10 ACGVGKSALT20 IQLIQNHFVD30 EDSYRKQVVI46 DGETSLLDIL56 DTAGQEEYSA 66 MRDQYMRTGE76 GFLLVFAINN86 TKSFEDIHHY96 REQIKRVKDS106 EDVPMVLVGN 116 KSDLPSRTVD126 TKQAQDLARS136 YGIPFIETSA146 KTRQGVDDAF156 YTLVREIRKH 166 K
|
|||||
Click to Show 3D Structure of This Binding Site
set background white;style ions nothing; color 8e8e8e;style chemicals nothing; select .GDP or .GDP2 or .GDP3 or :3GDP;style chemicals stick;color identity;select .A:11 or .A:12 or .A:13 or .A:14 or .A:15 or .A:16 or .A:17 or .A:18 or .A:19 or .A:28 or .A:29 or .A:30 or .A:57 or .A:116 or .A:117 or .A:118 or .A:119 or .A:120 or .A:144 or .A:145 or .A:146 or .A:147; color #f3c393; zoom selection;set surface opacity 0.5;set surface Van der Waals surface;set mode all
|
ALA11
3.845
CYS12
3.226
GLY13
1.969
VAL14
2.919
GLY15
2.214
LYS16
1.899
SER17
2.054
ALA18
2.084
LEU19
4.670
PHE28
3.006
VAL29
2.953
|
|||||
PDB ID: 4M1W Crystal Structure of small molecule vinylsulfonamide covalently bound to K-Ras G12C | ||||||
Method | X-ray diffraction | Resolution | 1.58 Å | Mutation | Yes | [11] |
PDB Sequence |
MTEYKLVVVG
10 ACGVGKSALT20 IQLIQNHFVD30 EDSYRKQVVI46 DGETSLLDIL56 DTAGQESAMR 68 DQYMRTGEGF78 LLVFAINNTK88 SFEDIHHYRE98 QIKRVKDSED108 VPMVLVGNKS 118 DLPSRTVDTK128 QAQDLARSYG138 IPFIETSAKT148 RQGVDDAFYT158 LVREIRKHKE 168
|
|||||
Click to Show 3D Structure of This Binding Site
set background white;style ions nothing; color 8e8e8e;style chemicals nothing; select .GDP or .GDP2 or .GDP3 or :3GDP;style chemicals stick;color identity;select .A:11 or .A:12 or .A:13 or .A:14 or .A:15 or .A:16 or .A:17 or .A:18 or .A:19 or .A:28 or .A:29 or .A:30 or .A:57 or .A:116 or .A:117 or .A:118 or .A:119 or .A:120 or .A:144 or .A:145 or .A:146 or .A:147 or .A:148; color #00ffc7; zoom selection;set surface opacity 0.5;set surface Van der Waals surface;set mode all
|
ALA11
3.865
CYS12
3.147
GLY13
1.971
VAL14
2.911
GLY15
2.216
LYS16
1.943
SER17
2.052
ALA18
2.018
LEU19
4.672
PHE28
2.993
VAL29
2.959
ASP30
2.512
|
|||||
PDB ID: 7R0M KRasG12C in complex with GDP and JDQ443 | ||||||
Method | X-ray diffraction | Resolution | 1.61 Å | Mutation | Yes | [10] |
PDB Sequence |
MTEYKLVVVG
10 ACGVGKSALT20 IQLIQNHFVD30 EYDPTIEDSY40 RKQVVIDGET50 SLLDILDTAG 60 QEEYSAMRDQ70 YMRTGEGFLL80 VFAINNTKSF90 EDIHHYREQI100 KRVKDSEDVP 110 MVLVGNKSDL120 PSRTVDTKQA130 QDLARSYGIP140 FIETSAKTRQ150 GVDDAFYTLV 160 REIRKHKE
|
|||||
Click to Show 3D Structure of This Binding Site
set background white;style ions nothing; color 8e8e8e;style chemicals nothing; select .GDP or .GDP2 or .GDP3 or :3GDP;style chemicals stick;color identity;select .A:11 or .A:12 or .A:13 or .A:14 or .A:15 or .A:16 or .A:17 or .A:18 or .A:28 or .A:29 or .A:30 or .A:31 or .A:32 or .A:57 or .A:116 or .A:117 or .A:118 or .A:119 or .A:120 or .A:144 or .A:145 or .A:146 or .A:147; color #f3c393; zoom selection;set surface opacity 0.5;set surface Van der Waals surface;set mode all
|
ALA11
3.676
CYS12
3.812
GLY13
2.812
VAL14
3.201
GLY15
2.996
LYS16
2.830
SER17
3.086
ALA18
2.852
PHE28
3.116
VAL29
3.412
ASP30
2.752
GLU31
3.846
|
|||||
PDB ID: 6TAM X-RAY STRUCTURE OF HUMAN K-RAS G12C IN COMPLEX WITH COVALENT ISOQUINOLINONE INHIBITOR (COMPOUND 3) | ||||||
Method | X-ray diffraction | Resolution | 1.64 Å | Mutation | Yes | [8] |
PDB Sequence |
GMTEYKLVVV
9 GACGVGKSAL19 TIQLIQNHFV29 DEYDPTIEDS39 YRKQVVIDGE49 TSLLDILDTA 59 GQEEYSAMRD69 QYMRTGEGFL79 LVFAINNTKS89 FEDIHHYREQ99 IKRVKDSEDV 109 PMVLVGNKSD119 LPSRTVDTKQ129 AQDLARSYGI139 PFIETSAKTR149 QGVDDAFYTL 159 VREIRKHKEK169
|
|||||
Click to Show 3D Structure of This Binding Site
set background white;style ions nothing; color 8e8e8e;style chemicals nothing; select .GDP or .GDP2 or .GDP3 or :3GDP;style chemicals stick;color identity;select .A:11 or .A:12 or .A:13 or .A:14 or .A:15 or .A:16 or .A:17 or .A:18 or .A:28 or .A:29 or .A:30 or .A:31 or .A:32 or .A:34 or .A:57 or .A:116 or .A:117 or .A:118 or .A:119 or .A:120 or .A:144 or .A:145 or .A:146 or .A:147; color #00ffc7; zoom selection;set surface opacity 0.5;set surface Van der Waals surface;set mode all
|
ALA11
3.813
CYS12
3.915
GLY13
2.871
VAL14
3.350
GLY15
3.051
LYS16
2.772
SER17
3.006
ALA18
2.839
PHE28
3.426
VAL29
4.740
ASP30
2.783
GLU31
4.706
|
|||||
PDB ID: 5YY1 Co-crystal Structure of KRAS (G12C) covalently bound with Quinazoline based inhibitor JBI739 | ||||||
Method | X-ray diffraction | Resolution | 1.69 Å | Mutation | Yes | [17] |
PDB Sequence |
GMTEYKLVVV
9 GACGVGKSAL19 TIQLIQNHFV29 DEYDPTIEDS39 YRKQVVIDGE49 TSLLDILDTA 59 GQEEYSAMRD69 QYMRTGEGFL79 LVFAINNTKS89 FEDIHHYREQ99 IKRVKDSEDV 109 PMVLVGNKSD119 LPSRTVDTKQ129 AQDLARSYGI139 PFIETSAKTR149 QGVDDAFYTL 159 VREIRKHKEK169
|
|||||
Click to Show 3D Structure of This Binding Site
set background white;style ions nothing; color 8e8e8e;style chemicals nothing; select .GDP or .GDP2 or .GDP3 or :3GDP;style chemicals stick;color identity;select .A:11 or .A:12 or .A:13 or .A:14 or .A:15 or .A:16 or .A:17 or .A:18 or .A:28 or .A:29 or .A:30 or .A:31 or .A:32 or .A:57 or .A:116 or .A:117 or .A:118 or .A:119 or .A:120 or .A:144 or .A:145 or .A:146 or .A:147; color #f3c393; zoom selection;set surface opacity 0.5;set surface Van der Waals surface;set mode all
|
ALA11
3.750
CYS12
3.811
GLY13
2.802
VAL14
3.389
GLY15
2.997
LYS16
2.736
SER17
3.018
ALA18
2.782
PHE28
3.278
VAL29
3.532
ASP30
2.719
GLU31
4.584
|
|||||
PDB ID: 4M1T Crystal Structure of small molecule vinylsulfonamide 14 covalently bound to K-Ras G12C | ||||||
Method | X-ray diffraction | Resolution | 1.70 Å | Mutation | Yes | [11] |
PDB Sequence |
MTEYKLVVVG
10 ACGVGKSALT20 IQLIQNHFVD30 IEDSYRKQVV45 IDGETSLLDI55 LDTAGQEEYS 65 AMRDQYMRTG75 EGFLLVFAIN85 NTKSFEDIHH95 YREQIKRVKD105 SEDVPMVLVG 115 NKSDLPSRTV125 DTKQAQDLAR135 SYGIPFIETS145 AKTRQGVDDA155 FYTLVREIRK 165 HKE
|
|||||
Click to Show 3D Structure of This Binding Site
set background white;style ions nothing; color 8e8e8e;style chemicals nothing; select .GDP or .GDP2 or .GDP3 or :3GDP;style chemicals stick;color identity;select .A:11 or .A:12 or .A:13 or .A:14 or .A:15 or .A:16 or .A:17 or .A:18 or .A:19 or .A:28 or .A:29 or .A:30 or .A:57 or .A:116 or .A:117 or .A:118 or .A:119 or .A:120 or .A:144 or .A:145 or .A:146 or .A:147 or .A:148; color #00ffc7; zoom selection;set surface opacity 0.5;set surface Van der Waals surface;set mode all
|
ALA11
3.909
CYS12
3.228
GLY13
2.036
VAL14
2.848
GLY15
2.212
LYS16
1.880
SER17
2.105
ALA18
2.053
LEU19
4.631
PHE28
3.010
VAL29
3.616
ASP30
2.606
|
|||||
PDB ID: 5V6S Crystal structure of small molecule acrylamide 1 covalently bound to K-Ras G12C | ||||||
Method | X-ray diffraction | Resolution | 1.70 Å | Mutation | Yes | [18] |
PDB Sequence |
GMTEYKLVVV
9 GACGVGKSAL19 TIQLIQNHFV29 DEYDPTIEDS39 YRKQVVIDGE49 TSLLDILDTA 59 GQEEYSAMRD69 QYMRTGEGFL79 LVFAINNTKS89 FEDIHHYREQ99 IKRVKDSEDV 109 PMVLVGNKSD119 LPSRTVDTKQ129 AQDLARSYGI139 PFIETSAKTR149 QGVDDAFYTL 159 VREIRKHKEK169
|
|||||
Click to Show 3D Structure of This Binding Site
set background white;style ions nothing; color 8e8e8e;style chemicals nothing; select .GDP or .GDP2 or .GDP3 or :3GDP;style chemicals stick;color identity;select .A:11 or .A:12 or .A:13 or .A:14 or .A:15 or .A:16 or .A:17 or .A:18 or .A:19 or .A:28 or .A:29 or .A:30 or .A:31 or .A:32 or .A:34 or .A:57 or .A:116 or .A:117 or .A:118 or .A:119 or .A:120 or .A:144 or .A:145 or .A:146 or .A:147 or .A:148; color #f3c393; zoom selection;set surface opacity 0.5;set surface Van der Waals surface;set mode all
|
ALA11
3.854
CYS12
3.350
GLY13
1.999
VAL14
3.002
GLY15
2.317
LYS16
1.912
SER17
2.246
ALA18
2.044
LEU19
4.562
PHE28
2.645
VAL29
2.122
ASP30
2.312
GLU31
3.822
|
|||||
PDB ID: 5YXZ Co-crystal Structure of KRAS (G12C) covalently bound with Quinazoline based inhibitor JBI484 | ||||||
Method | X-ray diffraction | Resolution | 1.70 Å | Mutation | Yes | [19] |
PDB Sequence |
GMTEYKLVVV
9 GACGVGKSAL19 TIQLIQNHFV29 DEYDPTIEDS39 YRKQVVIDGE49 TSLLDILDTA 59 GQEEYSAMRD69 QYMRTGEGFL79 LVFAINNTKS89 FEDIHHYREQ99 IKRVKDSEDV 109 PMVLVGNKSD119 LPSRTVDTKQ129 AQDLARSYGI139 PFIETSAKTR149 QGVDDAFYTL 159 VREIRKHKEK169
|
|||||
Click to Show 3D Structure of This Binding Site
set background white;style ions nothing; color 8e8e8e;style chemicals nothing; select .GDP or .GDP2 or .GDP3 or :3GDP;style chemicals stick;color identity;select .A:11 or .A:12 or .A:13 or .A:14 or .A:15 or .A:16 or .A:17 or .A:18 or .A:28 or .A:29 or .A:30 or .A:31 or .A:32 or .A:34 or .A:57 or .A:116 or .A:117 or .A:118 or .A:119 or .A:120 or .A:144 or .A:145 or .A:146 or .A:147; color #00ffc7; zoom selection;set surface opacity 0.5;set surface Van der Waals surface;set mode all
|
ALA11
3.838
CYS12
3.901
GLY13
2.832
VAL14
3.331
GLY15
3.024
LYS16
2.733
SER17
3.027
ALA18
2.759
PHE28
3.436
VAL29
3.842
ASP30
2.961
GLU31
4.666
|
|||||
PDB ID: 5V6V Crystal structure of small molecule aziridine 3 covalently bound to K-Ras G12C | ||||||
Method | X-ray diffraction | Resolution | 1.72 Å | Mutation | Yes | [18] |
PDB Sequence |
TEYKLVVVGA
11 CGVGKSALTI21 QLIQNHFVDE31 YDPTIEDSYR41 KQVVIDGETS51 LLDILDTAGQ 61 EEYSAMRDQY71 MRTGEGFLLV81 FAINNTKSFE91 DIHHYREQIK101 RVKDSEDVPM 111 VLVGNKSDLP121 SRTVDTKQAQ131 DLARSYGIPF141 IETSAKTRQG151 VDDAFYTLVR 161 EIRKHK
|
|||||
Click to Show 3D Structure of This Binding Site
set background white;style ions nothing; color 8e8e8e;style chemicals nothing; select .GDP or .GDP2 or .GDP3 or :3GDP;style chemicals stick;color identity;select .A:11 or .A:12 or .A:13 or .A:14 or .A:15 or .A:16 or .A:17 or .A:18 or .A:19 or .A:28 or .A:29 or .A:30 or .A:31 or .A:32 or .A:34 or .A:57 or .A:116 or .A:117 or .A:118 or .A:119 or .A:120 or .A:144 or .A:145 or .A:146 or .A:147 or .A:148; color #f3c393; zoom selection;set surface opacity 0.5;set surface Van der Waals surface;set mode all
|
ALA11
3.803
CYS12
3.455
GLY13
2.003
VAL14
2.815
GLY15
2.212
LYS16
1.858
SER17
2.160
ALA18
2.103
LEU19
4.649
PHE28
2.250
VAL29
2.964
ASP30
2.105
GLU31
2.250
|
|||||
PDB ID: 6N2K Tetrahydropyridopyrimidines as Covalent Inhibitors of KRAS-G12C | ||||||
Method | X-ray diffraction | Resolution | 1.72 Å | Mutation | Yes | [20] |
PDB Sequence |
MTEYKLVVVG
10 ACGVGKSALT20 IQLIQNHFVD30 EYDPTIEDSY40 RKQVVIDGET50 SLLDILDTAG 60 QEEYSAMRDQ70 YMRTGEGFLL80 VFAINNTKSF90 EDIHHYREQI100 KRVKDSEDVP 110 MVLVGNKSDL120 PSRTVDTKQA130 QDLARSYGIP140 FIETSAKTRQ150 GVDDAFYTLV 160 REIRKHKEK
|
|||||
Click to Show 3D Structure of This Binding Site
set background white;style ions nothing; color 8e8e8e;style chemicals nothing; select .GDP or .GDP2 or .GDP3 or :3GDP;style chemicals stick;color identity;select .A:11 or .A:12 or .A:13 or .A:14 or .A:15 or .A:16 or .A:17 or .A:18 or .A:28 or .A:29 or .A:30 or .A:31 or .A:32 or .A:34 or .A:57 or .A:116 or .A:117 or .A:118 or .A:119 or .A:120 or .A:144 or .A:145 or .A:146 or .A:147; color #00ffc7; zoom selection;set surface opacity 0.5;set surface Van der Waals surface;set mode all
|
ALA11
3.773
CYS12
3.846
GLY13
2.830
VAL14
3.280
GLY15
3.012
LYS16
2.791
SER17
2.939
ALA18
2.789
PHE28
3.199
VAL29
2.735
ASP30
2.631
GLU31
4.503
|
|||||
PDB ID: 6ARK Crystal Structure of compound 10 covalently bound to K-Ras G12C | ||||||
Method | X-ray diffraction | Resolution | 1.75 Å | Mutation | Yes | [21] |
PDB Sequence |
GMTEYKLVVV
9 GACGVGKSAL19 TIQLIQNHFV29 DEYDPTIEDS39 YRKQVVIDGE49 TSLLDILDTA 59 GQEMRDQYMR73 TGEGFLLVFA83 INNTKSFEDI93 HHYREQIKRV103 KDSEDVPMVL 113 VGNKSDLPSR123 TVDTKQAQDL133 ARSYGIPFIE143 TSAKTRQGVD153 DAFYTLVREI 163 RKHKEK
|
|||||
Click to Show 3D Structure of This Binding Site
set background white;style ions nothing; color 8e8e8e;style chemicals nothing; select .GDP or .GDP2 or .GDP3 or :3GDP;style chemicals stick;color identity;select .A:11 or .A:12 or .A:13 or .A:14 or .A:15 or .A:16 or .A:17 or .A:18 or .A:19 or .A:28 or .A:29 or .A:30 or .A:31 or .A:32 or .A:34 or .A:57 or .A:116 or .A:117 or .A:118 or .A:119 or .A:120 or .A:144 or .A:145 or .A:146 or .A:147 or .A:148; color #f3c393; zoom selection;set surface opacity 0.5;set surface Van der Waals surface;set mode all
|
ALA11
3.810
CYS12
3.233
GLY13
2.040
VAL14
2.889
GLY15
2.119
LYS16
1.678
SER17
2.091
ALA18
2.111
LEU19
4.773
PHE28
2.249
VAL29
2.666
ASP30
2.429
GLU31
3.424
|
|||||
PDB ID: 7A1W KRASG12C GDP form in complex with Cpd3 | ||||||
Method | X-ray diffraction | Resolution | 1.76 Å | Mutation | Yes | [13] |
PDB Sequence |
MTEYKLVVVG
10 ACGVGKSALT20 IQLIQNHFVD30 EYDPTIEDSY40 RKQVVIDGET50 CLLDILDTAG 60 QEEYSAMRDQ70 YMRTGEGFLC80 VFAINNTKSF90 EDIHHYREQI100 KRVKDSEDVP 110 MVLVGNKCDL120 PSRTVDTKQA130 QDLARSYGIP140 FIETSAKTRQ150 GVDDAFYTLV 160 REIRKH
|
|||||
Click to Show 3D Structure of This Binding Site
set background white;style ions nothing; color 8e8e8e;style chemicals nothing; select .GDP or .GDP2 or .GDP3 or :3GDP;style chemicals stick;color identity;select .A:11 or .A:12 or .A:13 or .A:14 or .A:15 or .A:16 or .A:17 or .A:18 or .A:28 or .A:29 or .A:30 or .A:31 or .A:32 or .A:34 or .A:57 or .A:116 or .A:117 or .A:118 or .A:119 or .A:120 or .A:144 or .A:145 or .A:146 or .A:147; color #00ffc7; zoom selection;set surface opacity 0.5;set surface Van der Waals surface;set mode all
|
ALA11
3.926
CYS12
3.749
GLY13
2.769
VAL14
3.466
GLY15
3.085
LYS16
2.706
SER17
2.975
ALA18
2.832
PHE28
3.241
VAL29
2.865
ASP30
2.828
GLU31
4.362
|
|||||
PDB ID: 7YCC KRas G12C in complex with Compound 5c | ||||||
Method | X-ray diffraction | Resolution | 1.79 Å | Mutation | Yes | [22] |
PDB Sequence |
MTEYKLVVVG
10 ACGVGKSALT20 IQLIQNHFVD30 EYDPTIEDSY40 RKQVVIDGET50 CLLDILDTAG 60 QEMRDQYMRT74 GEGFLCVFAI84 NNTKSFEDIH94 HYREQIKRVK104 DSEDVPMVLV 114 GNKSDLPSRT124 VDTKQAQDLA134 RSYGIPFIET144 SAKTRQGVDD154 AFYTLVREIR 164 KHKEK
|
|||||
Click to Show 3D Structure of This Binding Site
set background white;style ions nothing; color 8e8e8e;style chemicals nothing; select .GDP or .GDP2 or .GDP3 or :3GDP;style chemicals stick;color identity;select .A:11 or .A:12 or .A:13 or .A:14 or .A:15 or .A:16 or .A:17 or .A:18 or .A:19 or .A:28 or .A:29 or .A:30 or .A:31 or .A:32 or .A:57 or .A:116 or .A:117 or .A:118 or .A:119 or .A:120 or .A:144 or .A:145 or .A:146 or .A:147; color #f3c393; zoom selection;set surface opacity 0.5;set surface Van der Waals surface;set mode all
|
ALA11
3.612
CYS12
3.738
GLY13
2.694
VAL14
3.454
GLY15
3.087
LYS16
2.498
SER17
2.966
ALA18
2.618
LEU19
4.908
PHE28
3.441
VAL29
3.120
ASP30
2.711
|
|||||
PDB ID: 6N2J Tetrahydropyridopyrimidines as Covalent Inhibitors of KRAS-G12C | ||||||
Method | X-ray diffraction | Resolution | 1.80 Å | Mutation | Yes | [20] |
PDB Sequence |
TEYKLVVVGA
11 CGVGKSALTI21 QLIQNHFVDE31 YDPTIEDSYR41 KQVVIDGETS51 LLDILDTAGQ 61 EEYSAMRDQY71 MRTGEGFLLV81 FAINNTKSFE91 DIHHYREQIK101 RVKDSEDVPM 111 VLVGNKSDLP121 SRTVDTKQAQ131 DLARSYGIPF141 IETSAKTRQG151 VDDAFYTLVR 161 EIRKHKEK
|
|||||
Click to Show 3D Structure of This Binding Site
set background white;style ions nothing; color 8e8e8e;style chemicals nothing; select .GDP or .GDP2 or .GDP3 or :3GDP;style chemicals stick;color identity;select .A:11 or .A:12 or .A:13 or .A:14 or .A:15 or .A:16 or .A:17 or .A:18 or .A:28 or .A:29 or .A:30 or .A:31 or .A:32 or .A:57 or .A:116 or .A:117 or .A:118 or .A:119 or .A:120 or .A:144 or .A:145 or .A:146 or .A:147; color #00ffc7; zoom selection;set surface opacity 0.5;set surface Van der Waals surface;set mode all
|
ALA11
3.698
CYS12
3.730
GLY13
2.737
VAL14
3.320
GLY15
3.073
LYS16
2.794
SER17
2.990
ALA18
2.797
PHE28
3.232
VAL29
3.030
ASP30
2.682
GLU31
4.391
|
|||||
PDB ID: 7YCE KRas G12C in complex with Compound 7b | ||||||
Method | X-ray diffraction | Resolution | 1.80 Å | Mutation | Yes | [22] |
PDB Sequence |
MTEYKLVVVG
10 ACGVGKSALT20 IQLIQNHFVD30 EYDPTIEDSY40 RKQVVIDGET50 CLLDILDTAG 60 QEEYSAMRDQ70 YMRTGEGFLC80 VFAINNTKSF90 EDIHHYREQI100 KRVKDSEDVP 110 MVLVGNKSDL120 PSRTVDTKQA130 QDLARSYGIP140 FIETSAKTRQ150 GVDDAFYTLV 160 REIRKHKEK
|
|||||
Click to Show 3D Structure of This Binding Site
set background white;style ions nothing; color 8e8e8e;style chemicals nothing; select .GDP or .GDP2 or .GDP3 or :3GDP;style chemicals stick;color identity;select .A:11 or .A:12 or .A:13 or .A:14 or .A:15 or .A:16 or .A:17 or .A:18 or .A:19 or .A:28 or .A:29 or .A:30 or .A:31 or .A:32 or .A:57 or .A:116 or .A:117 or .A:118 or .A:119 or .A:120 or .A:144 or .A:145 or .A:146 or .A:147; color #f3c393; zoom selection;set surface opacity 0.5;set surface Van der Waals surface;set mode all
|
ALA11
3.759
CYS12
3.812
GLY13
2.803
VAL14
3.427
GLY15
3.002
LYS16
2.731
SER17
2.933
ALA18
2.707
LEU19
4.956
PHE28
3.539
VAL29
3.052
ASP30
2.732
|
|||||
PDB ID: 4LYJ Crystal Structure of small molecule vinylsulfonamide 9 covalently bound to K-Ras G12C, alternative space group | ||||||
Method | X-ray diffraction | Resolution | 1.93 Å | Mutation | Yes | [11] |
PDB Sequence |
TEYKLVVVGA
11 CGVGKSALTI21 QLIQNHFVDE31 YDPTIEDSYR41 KQVVIDGETS51 LLDILDTAGQ 61 EEYSAMRDQY71 MRTGEGFLLV81 FAINNTKSFE91 DIHHYREQIK101 RVKDSEDVPM 111 VLVGNKSDLP121 SRTVDTKQAQ131 DLARSYGIPF141 IETSAKTRQG151 VDDAFYTLVR 161 EIRKHK
|
|||||
Click to Show 3D Structure of This Binding Site
set background white;style ions nothing; color 8e8e8e;style chemicals nothing; select .GDP or .GDP2 or .GDP3 or :3GDP;style chemicals stick;color identity;select .A:11 or .A:12 or .A:13 or .A:14 or .A:15 or .A:16 or .A:17 or .A:18 or .A:28 or .A:29 or .A:30 or .A:31 or .A:32 or .A:62 or .A:116 or .A:117 or .A:118 or .A:119 or .A:120 or .A:144 or .A:145 or .A:146 or .A:147; color #00ffc7; zoom selection;set surface opacity 0.5;set surface Van der Waals surface;set mode all
|
ALA11
3.699
CYS12
4.012
GLY13
2.951
VAL14
3.289
GLY15
3.091
LYS16
2.656
SER17
2.950
ALA18
2.893
PHE28
3.397
VAL29
2.891
ASP30
2.969
GLU31
4.807
|
|||||
PDB ID: 4M21 Crystal Structure of small molecule acrylamide 11 covalently bound to K-Ras G12C | ||||||
Method | X-ray diffraction | Resolution | 1.94 Å | Mutation | Yes | [11] |
PDB Sequence |
MTEYKLVVVG
10 ACGVGKSALT20 IQLIQNHFVD30 IEDSYRKQVV45 IDGETSLLDI55 LDTAGQSAMR 68 DQYMRTGEGF78 LLVFAINNTK88 SFEDIHHYRE98 QIKRVKDSED108 VPMVLVGNKS 118 DLPSRTVDTK128 QAQDLARSYG138 IPFIETSAKT148 RQGVDDAFYT158 LVREIRKHK |
|||||
Click to Show 3D Structure of This Binding Site
set background white;style ions nothing; color 8e8e8e;style chemicals nothing; select .GDP or .GDP2 or .GDP3 or :3GDP;style chemicals stick;color identity;select .A:11 or .A:12 or .A:13 or .A:14 or .A:15 or .A:16 or .A:17 or .A:18 or .A:19 or .A:28 or .A:29 or .A:30 or .A:57 or .A:116 or .A:117 or .A:118 or .A:119 or .A:120 or .A:144 or .A:145 or .A:146 or .A:147 or .A:148; color #f3c393; zoom selection;set surface opacity 0.5;set surface Van der Waals surface;set mode all
|
ALA11
3.880
CYS12
3.316
GLY13
2.064
VAL14
2.895
GLY15
2.280
LYS16
1.809
SER17
2.134
ALA18
2.132
LEU19
4.738
PHE28
3.016
VAL29
3.072
ASP30
2.665
|
|||||
PDB ID: 6UT0 Identification of the Clinical Development Candidate MRTX849, a Covalent KRASG12C Inhibitor for the Treatment of Cancer | ||||||
Method | X-ray diffraction | Resolution | 1.94 Å | Mutation | Yes | [23] |
PDB Sequence |
MTEYKLVVVG
10 ACGVGKSALT20 IQLIQNHFVD30 EYDPTIEDSY40 RKQVVIDGET50 SLLDILDTAG 60 QEEYSAMRDQ70 YMRTGEGFLL80 VFAINNTKSF90 EDIHHYREQI100 KRVKDSEDVP 110 MVLVGNKSDL120 PSRTVDTKQA130 QDLARSYGIP140 FIETSAKTRQ150 GVDDAFYTLV 160 REIRKHKEK
|
|||||
Click to Show 3D Structure of This Binding Site
set background white;style ions nothing; color 8e8e8e;style chemicals nothing; select .GDP or .GDP2 or .GDP3 or :3GDP;style chemicals stick;color identity;select .A:11 or .A:12 or .A:13 or .A:14 or .A:15 or .A:16 or .A:17 or .A:18 or .A:19 or .A:28 or .A:29 or .A:30 or .A:31 or .A:32 or .A:34 or .A:57 or .A:116 or .A:117 or .A:118 or .A:119 or .A:120 or .A:144 or .A:145 or .A:146 or .A:147 or .A:148; color #00ffc7; zoom selection;set surface opacity 0.5;set surface Van der Waals surface;set mode all
|
ALA11
3.710
CYS12
3.107
GLY13
1.917
VAL14
2.865
GLY15
2.281
LYS16
1.773
SER17
2.188
ALA18
1.988
LEU19
4.420
PHE28
2.666
VAL29
3.961
ASP30
1.720
GLU31
3.642
|
|||||
PDB ID: 7R0Q KRasG12C in complex with GDP and compound 3 | ||||||
Method | X-ray diffraction | Resolution | 1.95 Å | Mutation | Yes | [10] |
PDB Sequence |
MTEYKLVVVG
10 ACGVGKSALT20 IQLIQNHFVD30 EYDPTIEDSY40 RKQVVIDGET50 SLLDILDTAG 60 QEEYSAMRDQ70 YMRTGEGFLL80 VFAINNTKSF90 EDIHHYREQI100 KRVKDSEDVP 110 MVLVGNKSDL120 PSRTVDTKQA130 QDLARSYGIP140 FIETSAKTRQ150 GVDDAFYTLV 160 REIRKHKE
|
|||||
Click to Show 3D Structure of This Binding Site
set background white;style ions nothing; color 8e8e8e;style chemicals nothing; select .GDP or .GDP2 or .GDP3 or :3GDP;style chemicals stick;color identity;select .A:11 or .A:12 or .A:13 or .A:14 or .A:15 or .A:16 or .A:17 or .A:18 or .A:28 or .A:29 or .A:30 or .A:31 or .A:32 or .A:57 or .A:116 or .A:117 or .A:118 or .A:119 or .A:120 or .A:144 or .A:145 or .A:146 or .A:147; color #f3c393; zoom selection;set surface opacity 0.5;set surface Van der Waals surface;set mode all
|
ALA11
3.627
CYS12
3.999
GLY13
2.965
VAL14
3.135
GLY15
3.088
LYS16
2.648
SER17
3.015
ALA18
2.879
PHE28
3.341
VAL29
3.640
ASP30
2.683
GLU31
4.895
|
|||||
PDB ID: 7A1Y KRASG12C GDP form in complex with Cpd2 | ||||||
Method | X-ray diffraction | Resolution | 2.00 Å | Mutation | Yes | [13] |
PDB Sequence |
MTEYKLVVVG
10 ACGVGKSALT20 IQLIQNHFVD30 EYDPTIEDSY40 RKQVVIDGET50 CLLDILDTAG 60 QEEYMRDQYM72 RTGEGFLCVF82 AINNTKSFED92 IHHYREQIKR102 VKDSEDVPMV 112 LVGNKCDLPS122 RTVDTKQAQD132 LARSYGIPFI142 ETSAKTRQGV152 DDAFYTLVRE 162 IRKHKEK
|
|||||
Click to Show 3D Structure of This Binding Site
set background white;style ions nothing; color 8e8e8e;style chemicals nothing; select .GDP or .GDP2 or .GDP3 or :3GDP;style chemicals stick;color identity;select .A:11 or .A:12 or .A:13 or .A:14 or .A:15 or .A:16 or .A:17 or .A:18 or .A:28 or .A:29 or .A:30 or .A:31 or .A:32 or .A:34 or .A:57 or .A:116 or .A:117 or .A:118 or .A:119 or .A:120 or .A:144 or .A:145 or .A:146 or .A:147; color #00ffc7; zoom selection;set surface opacity 0.5;set surface Van der Waals surface;set mode all
|
ALA11
3.836
CYS12
3.791
GLY13
2.841
VAL14
3.403
GLY15
3.093
LYS16
2.790
SER17
2.991
ALA18
2.853
PHE28
3.292
VAL29
2.593
ASP30
2.606
GLU31
4.146
|
|||||
PDB ID: 6USZ Identification of the Clinical Development Candidate MRTX849, a Covalent KRASG12C Inhibitor for the Treatment of Cancer | ||||||
Method | X-ray diffraction | Resolution | 2.03 Å | Mutation | Yes | [23] |
PDB Sequence |
MTEYKLVVVG
10 ACGVGKSALT20 IQLIQNHFVD30 EYDPTIEDSY40 RKQVVIDGET50 SLLDILDTAG 60 QEEYSAMRDQ70 YMRTGEGFLL80 VFAINNTKSF90 EDIHHYREQI100 KRVKDSEDVP 110 MVLVGNKSDL120 PSRTVDTKQA130 QDLARSYGIP140 FIETSAKTRQ150 GVDDAFYTLV 160 REIRKHKEK
|
|||||
Click to Show 3D Structure of This Binding Site
set background white;style ions nothing; color 8e8e8e;style chemicals nothing; select .GDP or .GDP2 or .GDP3 or :3GDP;style chemicals stick;color identity;select .A:11 or .A:12 or .A:13 or .A:14 or .A:15 or .A:16 or .A:17 or .A:18 or .A:28 or .A:29 or .A:30 or .A:31 or .A:32 or .A:34 or .A:57 or .A:116 or .A:117 or .A:118 or .A:119 or .A:120 or .A:144 or .A:145 or .A:146 or .A:147; color #f3c393; zoom selection;set surface opacity 0.5;set surface Van der Waals surface;set mode all
|
ALA11
3.729
CYS12
3.801
GLY13
2.825
VAL14
3.389
GLY15
3.093
LYS16
2.637
SER17
2.944
ALA18
2.821
PHE28
3.194
VAL29
3.198
ASP30
2.666
GLU31
4.584
|
|||||
PDB ID: 4M22 Crystal Structure of small molecule acrylamide 16 covalently bound to K-Ras G12C | ||||||
Method | X-ray diffraction | Resolution | 2.09 Å | Mutation | Yes | [11] |
PDB Sequence |
MTEYKLVVVG
10 ACGVGKSALT20 IQLIQNHFVD30 EYDPTIEDSY40 RKQVVIDGET50 SLLDILDTAR 68 DQYMRTGEGF78 LLVFAINNTK88 SFEDIHHYRE98 QIKRVKDSED108 VPMVLVGNKS 118 DLPSRTVDTK128 QAQDLARSYG138 IPFIETSAKT148 RQGVDDAFYT158 LVREIRKHKE 168
|
|||||
Click to Show 3D Structure of This Binding Site
set background white;style ions nothing; color 8e8e8e;style chemicals nothing; select .GDP or .GDP2 or .GDP3 or :3GDP;style chemicals stick;color identity;select .A:11 or .A:12 or .A:13 or .A:14 or .A:15 or .A:16 or .A:17 or .A:18 or .A:19 or .A:28 or .A:29 or .A:30 or .A:31 or .A:32 or .A:34 or .A:57 or .A:116 or .A:117 or .A:118 or .A:119 or .A:120 or .A:144 or .A:145 or .A:146 or .A:147 or .A:148; color #00ffc7; zoom selection;set surface opacity 0.5;set surface Van der Waals surface;set mode all
|
ALA11
3.875
CYS12
3.132
GLY13
1.923
VAL14
2.901
GLY15
2.234
LYS16
1.869
SER17
2.204
ALA18
2.102
LEU19
4.581
PHE28
2.903
VAL29
2.729
ASP30
2.199
GLU31
3.503
|
|||||
PDB ID: 4LRW Crystal Structure of K-Ras G12C (cysteine-light), GDP-bound | ||||||
Method | X-ray diffraction | Resolution | 2.15 Å | Mutation | Yes | [11] |
PDB Sequence |
TEYKLVVVGA
11 CGVGKSALTI21 QLIQNHFVDE31 YDPTIEDSYR41 KQVVIDGETS51 LLDILDTAYM 72 RTGEGFLLVF82 AINNTKSFED92 IHHYREQIKR102 VKDSEDVPMV112 LVGNKSDLPS 122 RTVDTKQAQD132 LARSYGIPFI142 ETSAKTRQGV152 DDAFYTLVRE162 IRKHK |
|||||
Click to Show 3D Structure of This Binding Site
set background white;style ions nothing; color 8e8e8e;style chemicals nothing; select .GDP or .GDP2 or .GDP3 or :3GDP;style chemicals stick;color identity;select .A:11 or .A:12 or .A:13 or .A:14 or .A:15 or .A:16 or .A:17 or .A:18 or .A:28 or .A:29 or .A:30 or .A:31 or .A:32 or .A:57 or .A:116 or .A:117 or .A:118 or .A:119 or .A:120 or .A:144 or .A:145 or .A:146 or .A:147; color #f3c393; zoom selection;set surface opacity 0.5;set surface Van der Waals surface;set mode all
|
ALA11
3.966
CYS12
3.612
GLY13
2.648
VAL14
3.491
GLY15
3.004
LYS16
2.663
SER17
3.012
ALA18
2.927
PHE28
3.182
VAL29
3.085
ASP30
2.395
GLU31
3.468
|
|||||
PDB ID: 7RP4 Crystal structure of KRAS G12C in complex with GNE-1952 | ||||||
Method | X-ray diffraction | Resolution | 2.15 Å | Mutation | Yes | [5] |
PDB Sequence |
STEYKLVVVG
10 ACGVGKSALT20 IQLIQNHFVD30 EYDPTIEDSY40 RKQVVIDGET50 SLLDILDTAG 60 QEEYSAMRDQ70 YMRTGEGFLL80 VFAINNTKSF90 EDIHHYREQI100 KRVKDSEDVP 110 MVLVGNKSDL120 PSRTVDTKQA130 QDLARSYGIP140 FIETSAKTRQ150 GVDDAFYTLV 160 REIRKHKEK
|
|||||
Click to Show 3D Structure of This Binding Site
set background white;style ions nothing; color 8e8e8e;style chemicals nothing; select .GDP or .GDP2 or .GDP3 or :3GDP;style chemicals stick;color identity;select .A:11 or .A:12 or .A:13 or .A:14 or .A:15 or .A:16 or .A:17 or .A:18 or .A:28 or .A:29 or .A:30 or .A:31 or .A:32 or .A:34 or .A:57 or .A:116 or .A:117 or .A:118 or .A:119 or .A:120 or .A:144 or .A:145 or .A:146 or .A:147; color #00ffc7; zoom selection;set surface opacity 0.5;set surface Van der Waals surface;set mode all
|
ALA11
3.594
CYS12
4.105
GLY13
3.053
VAL14
3.545
GLY15
2.993
LYS16
2.562
SER17
2.850
ALA18
2.720
PHE28
3.152
VAL29
3.301
ASP30
2.273
GLU31
4.190
|
|||||
PDB ID: 7A47 KRASG12C GDP form in complex with Cpd4 | ||||||
Method | X-ray diffraction | Resolution | 2.16 Å | Mutation | Yes | [13] |
PDB Sequence |
MTEYKLVVVG
10 ACGVGKSALT20 IQLIQNHFVD30 EYDPTIEDSY40 RKQVVIDGET50 CLLDILDTAG 60 QEEYSAMRDQ70 YMRTGEGFLC80 VFAINNTKSF90 EDIHHYREQI100 KRVKDSEDVP 110 MVLVGNKCDL120 PSRTVDTKQA130 QDLARSYGIP140 FIETSAKTRQ150 GVDDAFYTLV 160 REIRKHK
|
|||||
Click to Show 3D Structure of This Binding Site
set background white;style ions nothing; color 8e8e8e;style chemicals nothing; select .GDP or .GDP2 or .GDP3 or :3GDP;style chemicals stick;color identity;select .A:11 or .A:12 or .A:13 or .A:14 or .A:15 or .A:16 or .A:17 or .A:18 or .A:28 or .A:29 or .A:30 or .A:32 or .A:57 or .A:59 or .A:116 or .A:117 or .A:118 or .A:119 or .A:120 or .A:144 or .A:145 or .A:146 or .A:147; color #f3c393; zoom selection;set surface opacity 0.5;set surface Van der Waals surface;set mode all
|
ALA11
3.886
CYS12
3.867
GLY13
2.873
VAL14
3.310
GLY15
3.024
LYS16
2.769
SER17
2.630
ALA18
2.789
PHE28
3.170
VAL29
3.750
ASP30
3.037
TYR32
4.995
|
|||||
PDB ID: 7RP2 Crystal structure of Kas G12C in complex with 2H11 CLAMP | ||||||
Method | X-ray diffraction | Resolution | 2.20 Å | Mutation | Yes | [5] |
PDB Sequence |
GMTEYKLVVV
9 GACGVGKSAL19 TIQLIQNHFV29 DEYDPTIEDS39 YRKQVVIDGE49 TSLLDILDTA 59 GQEEYSAMRD69 QYMRTGEGFL79 LVFAINNTKS89 FEDIHHYREQ99 IKRVKDSEDV 109 PMVLVGNKSD119 LPSRTVDTKQ129 AQDLARSYGI139 PFIETSAKTR149 QGVDDAFYTL 159 VREIRKHKEK169
|
|||||
Click to Show 3D Structure of This Binding Site
set background white;style ions nothing; color 8e8e8e;style chemicals nothing; select .GDP or .GDP2 or .GDP3 or :3GDP;style chemicals stick;color identity;select .A:11 or .A:12 or .A:13 or .A:14 or .A:15 or .A:16 or .A:17 or .A:18 or .A:28 or .A:29 or .A:30 or .A:31 or .A:32 or .A:34 or .A:57 or .A:116 or .A:117 or .A:118 or .A:119 or .A:120 or .A:144 or .A:145 or .A:146 or .A:147; color #00ffc7; zoom selection;set surface opacity 0.5;set surface Van der Waals surface;set mode all
|
ALA11
3.762
CYS12
4.067
GLY13
2.966
VAL14
3.585
GLY15
2.904
LYS16
2.446
SER17
2.942
ALA18
2.827
PHE28
3.359
VAL29
4.356
ASP30
2.957
GLU31
3.166
|
|||||
PDB ID: 6USX Identification of the Clinical Development Candidate MRTX849, a Covalent KRASG12C Inhibitor for the Treatment of Cancer | ||||||
Method | X-ray diffraction | Resolution | 2.27 Å | Mutation | Yes | [23] |
PDB Sequence |
MTEYKLVVVG
10 ACGVGKSALT20 IQLIQNHFVD30 EYDPTIEDSY40 RKQVVIDGET50 SLLDILDTAG 60 QEEYSAMRDQ70 YMRTGEGFLL80 VFAINNTKSF90 EDIHHYREQI100 KRVKDSEDVP 110 MVLVGNKSDL120 PSRTVDTKQA130 QDLARSYGIP140 FIETSAKTRQ150 GVDDAFYTLV 160 REIRKHK
|
|||||
Click to Show 3D Structure of This Binding Site
set background white;style ions nothing; color 8e8e8e;style chemicals nothing; select .GDP or .GDP2 or .GDP3 or :3GDP;style chemicals stick;color identity;select .A:11 or .A:12 or .A:13 or .A:14 or .A:15 or .A:16 or .A:17 or .A:18 or .A:19 or .A:28 or .A:29 or .A:30 or .A:31 or .A:32 or .A:34 or .A:57 or .A:116 or .A:117 or .A:118 or .A:119 or .A:120 or .A:144 or .A:145 or .A:146 or .A:147; color #f3c393; zoom selection;set surface opacity 0.5;set surface Van der Waals surface;set mode all
|
ALA11
3.664
CYS12
3.092
GLY13
1.982
VAL14
2.948
GLY15
2.276
LYS16
1.926
SER17
2.034
ALA18
2.009
LEU19
4.637
PHE28
2.771
VAL29
1.978
ASP30
1.967
GLU31
1.367
|
|||||
PDB ID: 7OO7 KRasG12C ligand complex | ||||||
Method | X-ray diffraction | Resolution | 1.48 Å | Mutation | Yes | [9] |
PDB Sequence |
GMTEYKLVVV
9 GACGVGKSAL19 TIQLIQNHFV29 DEYDPTIEDS39 YRKQVVIDGE49 TSLLDILDTA 59 GQEEYSAMRD69 QYMRTGEGFL79 LVFAINNTKS89 FEDIHHYREQ99 IKRVKDSEDV 109 PMVLVGNKSD119 LPSRTVDTKQ129 AQDLARSYGI139 PFIETSAKTR149 QGVDDAFYTL 159 VREIRKHK
|
|||||
Click to Show 3D Structure of This Binding Site
set background white;style ions nothing; color 8e8e8e;style chemicals nothing; select .GDP or .GDP2 or .GDP3 or :3GDP;style chemicals stick;color identity;select .A:11 or .A:12 or .A:13 or .A:14 or .A:15 or .A:16 or .A:17 or .A:18 or .A:19 or .A:28 or .A:29 or .A:30 or .A:31 or .A:32 or .A:57 or .A:116 or .A:117 or .A:118 or .A:119 or .A:120 or .A:144 or .A:145 or .A:146 or .A:147; color #00ffc7; zoom selection;set surface opacity 0.5;set surface Van der Waals surface;set mode all
|
ALA11
3.807
CYS12
3.964
GLY13
2.973
VAL14
3.421
GLY15
3.113
LYS16
2.744
SER17
2.932
ALA18
2.741
LEU19
4.962
PHE28
3.135
VAL29
2.839
ASP30
2.803
|
|||||
PDB ID: 5V9O KRAS G12C inhibitor | ||||||
Method | X-ray diffraction | Resolution | 1.56 Å | Mutation | Yes | [24] |
PDB Sequence |
MTEYKLVVVG
10 ACGVGKSALT20 IQLIQNHFVD30 EYDPTIEDSY40 RKQVVIDGET50 CLLDILDTAG 60 QEEYSAMRDQ70 YMRTGEGFLC80 VFAINNTKSF90 EDIHHYREQI100 KRVKDSEDVP 110 MVLVGNKCDL120 PSRTVDTKQA130 QDLARSYGIP140 FIETSAKTRQ150 GVDDAFYTLV 160 REIRKHKE
|
|||||
Click to Show 3D Structure of This Binding Site
set background white;style ions nothing; color 8e8e8e;style chemicals nothing; select .GDP or .GDP2 or .GDP3 or :3GDP;style chemicals stick;color identity;select .A:11 or .A:12 or .A:13 or .A:14 or .A:15 or .A:16 or .A:17 or .A:18 or .A:19 or .A:28 or .A:29 or .A:30 or .A:31 or .A:32 or .A:57 or .A:116 or .A:117 or .A:118 or .A:119 or .A:120 or .A:144 or .A:145 or .A:146 or .A:147; color #f3c393; zoom selection;set surface opacity 0.5;set surface Van der Waals surface;set mode all
|
ALA11
3.769
CYS12
3.839
GLY13
2.785
VAL14
3.318
GLY15
3.065
LYS16
2.807
SER17
2.934
ALA18
2.720
LEU19
4.868
PHE28
3.149
VAL29
3.011
ASP30
2.798
|
|||||
PDB ID: 7MDP KRas G12C in complex with G-2897 | ||||||
Method | X-ray diffraction | Resolution | 1.96 Å | Mutation | Yes | [5] |
PDB Sequence |
MTEYKLVVVG
10 ACGVGKSALT20 IQLIQNHFVD30 EYDPTIEDSY40 RKQVVIDGET50 CLLDILDTAG 60 QEEYSAMRDQ70 YMRTGEGFLC80 VFAINNTKSF90 EDIHHYREQI100 KRVKDSEDVP 110 MVLVGNKCDL120 PSRTVDTKQA130 QDLARSYGIP140 FIETSAKTRQ150 GVDDAFYTLV 160 REIRKHK
|
|||||
Click to Show 3D Structure of This Binding Site
set background white;style ions nothing; color 8e8e8e;style chemicals nothing; select .GDP or .GDP2 or .GDP3 or :3GDP;style chemicals stick;color identity;select .A:11 or .A:12 or .A:13 or .A:14 or .A:15 or .A:16 or .A:17 or .A:18 or .A:28 or .A:29 or .A:30 or .A:31 or .A:32 or .A:34 or .A:57 or .A:116 or .A:117 or .A:119 or .A:120 or .A:144 or .A:145 or .A:146 or .A:147; color #00ffc7; zoom selection;set surface opacity 0.5;set surface Van der Waals surface;set mode all
|
ALA11
3.758
CYS12
4.305
GLY13
3.154
VAL14
3.615
GLY15
2.832
LYS16
1.300
SER17
3.082
ALA18
3.161
PHE28
3.890
VAL29
4.716
ASP30
2.644
GLU31
3.603
|
|||||
PDB ID: 5V9L KRAS G12C in bound to quinazoline based switch II pocket (SWIIP) binder | ||||||
Method | X-ray diffraction | Resolution | 1.98 Å | Mutation | Yes | [24] |
PDB Sequence |
GMTEYKLVVV
9 GACGVGKSAL19 TIQLIQNHFV29 DEYDPTIEDS39 YRKQVVIDGE49 TCLLDILDTA 59 GQEEYSAMRD69 QYMRTGEGFL79 CVFAINNTKS89 FEDIHHYREQ99 IKRVKDSEDV 109 PMVLVGNKCD119 LPSRTVDTKQ129 AQDLARSYGI139 PFIETSAKTR149 QGVDDAFYTL 159 VREIRKHKE
|
|||||
Click to Show 3D Structure of This Binding Site
set background white;style ions nothing; color 8e8e8e;style chemicals nothing; select .GDP or .GDP2 or .GDP3 or :3GDP;style chemicals stick;color identity;select .A:11 or .A:12 or .A:13 or .A:14 or .A:15 or .A:16 or .A:17 or .A:18 or .A:28 or .A:29 or .A:30 or .A:31 or .A:32 or .A:34 or .A:57 or .A:116 or .A:117 or .A:118 or .A:119 or .A:120 or .A:144 or .A:145 or .A:146 or .A:147; color #f3c393; zoom selection;set surface opacity 0.5;set surface Van der Waals surface;set mode all
|
ALA11
3.834
CYS12
3.561
GLY13
2.469
VAL14
3.303
GLY15
2.993
LYS16
2.690
SER17
3.044
ALA18
2.834
PHE28
3.281
VAL29
3.564
ASP30
2.428
GLU31
4.418
|
|||||
PDB ID: 5V71 KRAS G12C in bound to quinazoline based switch II pocket (SWIIP) binder | ||||||
Method | X-ray diffraction | Resolution | 2.23 Å | Mutation | Yes | [25] |
PDB Sequence |
GMTEYKLVVV
9 GACGVGKSAL19 TIQLIQNHFV29 DEYDPTIEDS39 YRKQVVIDGE49 TCLLDILDTA 59 GQEEYSAMRD69 QYMRTGEGFL79 CVFAINNTKS89 FEDIHHYREQ99 IKRVKDSEDV 109 PMVLVGNKCD119 LPSRTVDTKQ129 AQDLARSYGI139 PFIETSAKTR149 QGVDDAFYTL 159 VREIRKHKE
|
|||||
Click to Show 3D Structure of This Binding Site
set background white;style ions nothing; color 8e8e8e;style chemicals nothing; select .GDP or .GDP2 or .GDP3 or :3GDP;style chemicals stick;color identity;select .A:11 or .A:12 or .A:13 or .A:14 or .A:15 or .A:16 or .A:17 or .A:18 or .A:19 or .A:28 or .A:29 or .A:30 or .A:31 or .A:32 or .A:34 or .A:57 or .A:116 or .A:117 or .A:118 or .A:119 or .A:120 or .A:144 or .A:145 or .A:146 or .A:147; color #00ffc7; zoom selection;set surface opacity 0.5;set surface Van der Waals surface;set mode all
|
ALA11
3.513
CYS12
4.040
GLY13
3.057
VAL14
3.313
GLY15
2.942
LYS16
2.612
SER17
2.745
ALA18
2.735
LEU19
4.949
PHE28
3.368
VAL29
2.889
ASP30
2.487
GLU31
4.389
|
|||||
PDB ID: 8AFC CRYSTAL STRUCTURE OF KRAS-G12C IN COMPLEX WITH COMPOUND 12 | ||||||
Method | X-ray diffraction | Resolution | 2.41 Å | Mutation | Yes | [6] |
PDB Sequence |
MTEYKLVVVG
10 ACGVGKSALT20 IQLIQNHFVD30 EYDPTIEDSY40 RKQVVIDGET50 CLLDILDTAG 60 QEEYSAMRDQ70 YMRTGEGFLC80 VFAINNTKSF90 EDIHHYREQI100 KRVKDSEDVP 110 MVLVGNKSDL120 PSRTVDTKQA130 QDLARSYGIP140 FIETSAKTRQ150 GVDDAFYTLV 160 REIRKHKEK
|
|||||
Click to Show 3D Structure of This Binding Site
set background white;style ions nothing; color 8e8e8e;style chemicals nothing; select .GDP or .GDP2 or .GDP3 or :3GDP;style chemicals stick;color identity;select .A:11 or .A:12 or .A:13 or .A:14 or .A:15 or .A:16 or .A:17 or .A:18 or .A:28 or .A:29 or .A:30 or .A:31 or .A:32 or .A:34 or .A:57 or .A:116 or .A:117 or .A:118 or .A:119 or .A:120 or .A:144 or .A:145 or .A:146 or .A:147; color #f3c393; zoom selection;set surface opacity 0.5;set surface Van der Waals surface;set mode all
|
ALA11
3.892
CYS12
4.029
GLY13
2.921
VAL14
3.368
GLY15
3.120
LYS16
2.778
SER17
2.985
ALA18
2.781
PHE28
3.477
VAL29
3.884
ASP30
2.776
GLU31
4.631
|
References | Top | ||||
---|---|---|---|---|---|
REF 1 | Discovery of a Covalent Inhibitor of KRAS(G12C) (AMG 510) for the Treatment of Solid Tumors. J Med Chem. 2020 Jan 9;63(1):52-65. | ||||
REF 2 | Modeling receptor flexibility in the structure-based design of KRAS(G12C) inhibitors. J Comput Aided Mol Des. 2022 Aug;36(8):591-604. | ||||
REF 3 | The clinical KRAS(G12C) inhibitor AMG 510 drives anti-tumour immunity. Nature. 2019 Nov;575(7781):217-223. | ||||
REF 4 | Discovery of N-(1-Acryloylazetidin-3-yl)-2-(1H-indol-1-yl)acetamides as Covalent Inhibitors of KRAS(G12C). ACS Med Chem Lett. 2019 Aug 20;10(9):1302-1308. | ||||
REF 5 | Conformation-locking antibodies for the discovery and characterization of KRAS inhibitors. Nat Biotechnol. 2022 May;40(5):769-778. | ||||
REF 6 | Fragment Optimization of Reversible Binding to the Switch II Pocket on KRAS Leads to a Potent, In Vivo Active KRAS(G12C) Inhibitor. J Med Chem. 2022 Nov 10;65(21):14614-14629. | ||||
REF 7 | In situ selectivity profiling and crystal structure of SML-8-73-1, an active site inhibitor of oncogenic K-Ras G12C. Proc Natl Acad Sci U S A. 2014 Jun 17;111(24):8895-900. | ||||
REF 8 | Computationally Empowered Workflow Identifies Novel Covalent Allosteric Binders for KRAS(G12C). ChemMedChem. 2020 May 19;15(10):827-832. | ||||
REF 9 | Discovery of AZD4625, a Covalent Allosteric Inhibitor of the Mutant GTPase KRAS(G12C). J Med Chem. 2022 May 12;65(9):6940-6952. | ||||
REF 10 | Discovery, Preclinical Characterization, and Early Clinical Activity of JDQ443, a Structurally Novel, Potent, and Selective Covalent Oral Inhibitor of KRASG12C. Cancer Discov. 2022 Jun 2;12(6):1500-1517. | ||||
REF 11 | K-Ras(G12C) inhibitors allosterically control GTP affinity and effector interactions. Nature. 2013 Nov 28;503(7477):548-51. | ||||
REF 12 | The reactivity-driven biochemical mechanism of covalent KRAS(G12C) inhibitors. Nat Struct Mol Biol. 2018 Jun;25(6):454-462. | ||||
REF 13 | KRAS G12C fragment screening renders new binding pockets. Small GTPases. 2022 Jan;13(1):225-238. | ||||
REF 14 | Structure-Based Design and Pharmacokinetic Optimization of Covalent Allosteric Inhibitors of the Mutant GTPase KRAS(G12C). J Med Chem. 2020 May 14;63(9):4468-4483. | ||||
REF 15 | Targeting KRAS Mutant Cancers with a Covalent G12C-Specific Inhibitor. Cell. 2018 Jan 25;172(3):578-589.e17. | ||||
REF 16 | Selective Inhibition of Oncogenic KRAS Output with Small Molecules Targeting the Inactive State. Cancer Discov. 2016 Mar;6(3):316-29. | ||||
REF 17 | Co-crystal Structure of KRAS (G12C) covalently bound with Quinazoline based inhibitor JBI739 | ||||
REF 18 | Expanding the Scope of Electrophiles Capable of Targeting K-Ras Oncogenes. Biochemistry. 2017 Jun 27;56(25):3178-3183. | ||||
REF 19 | Co-crystal Structure of KRAS (G12C) covalently bound with Quinazoline based inhibitor JBI484 | ||||
REF 20 | Discovery of Tetrahydropyridopyrimidines as Irreversible Covalent Inhibitors of KRAS-G12C with In Vivo Activity. ACS Med Chem Lett. 2018 Nov 7;9(12):1230-1234. | ||||
REF 21 | Novel K-Ras G12C Switch-II Covalent Binders Destabilize Ras and Accelerate Nucleotide Exchange. J Chem Inf Model. 2018 Feb 26;58(2):464-471. | ||||
REF 22 | Discovery and biological evaluation of 1-{2,7-diazaspiro[3.5]nonan-2-yl}prop-2-en-1-one derivatives as covalent inhibitors of KRAS G12C with favorable metabolic stability and anti-tumor activity. Bioorg Med Chem. 2022 Oct 1;71:116949. | ||||
REF 23 | Identification of the Clinical Development Candidate MRTX849, a Covalent KRAS(G12C) Inhibitor for the Treatment of Cancer. J Med Chem. 2020 Jul 9;63(13):6679-6693. | ||||
REF 24 | Potent and Selective Covalent Quinazoline Inhibitors of KRAS G12C. Cell Chem Biol. 2017 Aug 17;24(8):1005-1016.e3. | ||||
REF 25 | KRAS G12C Drug Development: Discrimination between Switch II Pocket Configurations Using Hydrogen/Deuterium-Exchange Mass Spectrometry. Structure. 2017 Sep 5;25(9):1442-1448.e3. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.